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General introduction
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Stroke and impairment in arm-hand function
A cerebrovascular accident, or stroke, is defined by the World Health Organization as “an 
interruption of the blood supply to the brain, usually because a blood vessel bursts or is 
blocked by a clot. This cuts off the supply of oxygen and nutrients, causing damage to the 
brain tissue”. The effects of a stroke depend on which part of the brain is injured and how 
severely it is affected [1]. Mortality directly after stroke is 15% [2]. 
Only 10% of stroke patients have a complete functional recovery [2]. In the Netherlands, it is 
estimated that the incidence of stroke is 0.5% [3] with a prevalence of 2.5%. That means that 
in a population of 17 million, there are around 85,000 new cases of stroke per year and over 
400,000 persons living with the consequences of stroke. Among them, 32-60% experience 
a lasting impairment in arm-hand function [4,5] and movement disorders such as spasticity 
[6,7], with resulting limitations in activities of daily living or in participation [5,8], e.g. social 
functioning, sports or work. 
Interventions directed at recovery of arm-hand function are either aimed at neural repair or 
at compensation methods and prevention of secondary complications. On the level of neural 
repair, early reperfusion with thrombolytic agents or mechanically by thrombectomy aim to 
minimize the damage in the first hours after stroke [9]; early hand therapy interventions aim 
to prevent learned non-use in the first days and weeks after stroke [10]. In the chronic phase 
after stroke, improvement in arm-hand function via neural repair is not to be expected [11]. 
Therefore, the focus in this phase lies on preventing secondary complications on the level of 
body structures and function; and on maximizing functioning on the level of activities and 
participation by compensation methods. Rehabilitation strategies range from task specific 
arm-hand training, robotics, splinting, stretching and botulinum toxin injections to surgery 
[12-15]. 
Clinical decision making
How to choose an appropriate rehabilitation strategy? Abovementioned therapies are 
often expensive and time consuming for both patients and therapists alike. Assigning the 
most effective intervention, however, not only depends on money and time, but also on 
an optimization of the time-window and selection of patients for a given intervention. 
Prediction models and biomarkers could support clinical decision making in this field 
[16]. For example: early return of wrist and finger extension and shoulder abduction after 
stroke is a key prognostic factor for regaining arm-hand function [4,10,17,18]. However, 
sensitivity and specificity of prediction models is seldom 100%. For example, prediction of 
proportional recovery fails in 30% of patients [19,20]. In this context, biomarkers of motor 
outcome play an important role, e.g. neuro-imaging and neurophysiological parameters to 
assess intactness of the corticospinal tract [16]. But these techniques do not fully bridge the 
gap towards endpoint joint behavior [21]. 
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Endpoint joint behavior is determined by motor control, stretch reflex properties and tissue 
properties. Movement disorders after stroke are the result of a complex interaction between 
neural deficits and changes in non-neural tissue properties [22,23], leading to a recognizable 
triad of paresis, muscle overactivity and contracture. Paresis is determined by decreased 
voluntary motor unit recruitment. Muscle overactivity (e.g. over-excitability of stretch 
reflexes and decreased selectivity of movement) is determined by increased involuntary 
motor unit recruitment. Contracture is determined by altered tissue properties and a 
changed position of the joint [24,25]. Biomarkers that accurately represent endpoint joint 
behavior (i.e. parameters with a high sensitivity and specificity) are required to assign and 
evaluate therapies both in the acute and chronic phase, and to reduce numbers of patients 
needed in research [21]. These data need to be collected objective and reproducible, which 
cannot always be achieved by using clinical scales [26,27]. 
Neuromechanics
Could neuromechanics be the essential element to represent and further specify endpoint 
joint behavior? Clinically, endpoint joint behavior is mostly described in terms such as paresis 
and spasticity, and measured with clinical scales. Neuromechanics provide a quantitative 
description of joint properties, both under passive and active conditions and as a reaction 
to external mechanical perturbations [28]. Variation in measurement conditions and tasks 
allows for the separation of neural contributors (motor control and stretch reflex properties) 
and non-neural contributors (tissue properties) to movement disorders after stroke, and for 
a more precise analysis of the non-linear properties of endpoint joint behavior [29] (e.g. for 
non-linearity: twice as much stretching does not result in twice as much resistance of the 
joint).
Biomechanical measuring devices (such as haptic robots, force/torque transducers and 
electrogoniometers) in combination with electromyography [27,30-32] allow variation in 
measurement conditions to objectify motor control, stretch reflexes and tissue properties 
in a reproducible manner. Furthermore, degrees of freedom of movement may be 
controlled, to allow or restrict compensation methods, providing valuable information 
on the pathophysiological mechanisms underlying functional recovery. For example, 
neuromechanical parameters can describe paresis not only in terms of force or torque, but 
also as lack of selective muscle activation or diminished active range of motion. And in case 
of a clinical phenomenon such as spasticity: tissue stiffness, stiffness due to reflex activity 
and modulation of reflexes in a changed environment can be distinguished. In summary, 
neuromechanical parameters may provide a comprehensive description of endpoint joint 
behavior with a strong link to underlying pathophysiological mechanisms.
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EXPLICIT-stroke project
The studies in this thesis were conducted within the framework of the Explaining PLastICITy 
after stroke (EXPLICIT-stroke) trial. This multicenter research program, consisting of a 
randomized clinical trial on the effects of early rehabilitation intervention on arm-hand 
function after stroke and a longitudinal survey into the dynamics of post-stroke recovery 
[10], aimed at improving arm-hand function by utilizing the window of opportunity for 
neural repair in the acute phase after stroke. Patients were stratified according to active 
wrist and finger extension within one week after stroke [10], based on the prediction model 
described earlier [4].
Parallel to clinical tests measuring arm-hand function, a selection of patients was assessed 
longitudinally by fMRI, TMS, kinematics and neuromechanics. The combination of clinical 
outcome measures, neuro-imaging, neurophysiological parameters and neuromechanics, 
aimed to enlarge the understanding of pathophysiological mechanisms of functional 
recovery after stroke. In short, EXPLICIT-stroke was designed to provide an answer to 
the key question whether improvement in arm-hand function in the first 6 months after 
stroke is due to a reduction of basic motor impairment by neural repair or by behavioral 
compensation methods.
Thesis outline
The aim of this thesis is to explore the neuromechanics of recovery of arm-hand function 
after stroke by assessing neural and non-neural contributors to movement disorders in 
the acute and chronic phase after stroke. Key questions are: How and to what extent does 
endpoint wrist joint behavior, as measured with neuromechanical parameters, change in 
the first 6 months after stroke? And how do those changes relate to functional outcome? 
[10] 
First, the gap is explored between day-to-day practice (i.e. physical examination) and the 
biomechanical and electrophysiological techniques recommended by research to support 
clinical decision making. An overview is given of regularly used pathophysiological concepts 
and biomechanical and electromyographical outcome measures of movement disorders 
after stroke (chapter 2).
Then, methodological aspects on how to address the different (nonlinear) neural and non-
neural properties of the wrist joint during flexion-extension movement are presented. The 
recommendations to apply multiple measurement and task conditions are assembled in 
a comprehensive and clinically applicable assessment protocol, to identify patients within 
the spectrum of neuromechanics and to understand the underlying pathophysiological 
mechanism of movement disorders after stroke (chapter 3).
Clinical responsiveness of the newly developed protocol and test-retest reliability are 
assessed in a cohort of stroke patients with impaired arm-hand function in the chronic phase 
after stroke and compared to a cohort of healthy participants (chapter 4). Complementary, 
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the roles of co-contraction and paresis on arm-hand function are investigated by assessing 
impairment in selective muscle activation. The methodology of measuring selective muscle 
activity by means of Activation Ratios is described and test-retest reliability and clinical 
responsiveness of this tool are presented (chapter 5).
Ultimately, changes in wrist neuromechanical parameters in the first 6 months after stroke 
are quantified by longitudinal data obtained with the comprehensive assessment protocol 
within the prospective cohort of the EXPLICIT trial. Neural and non-neural contributors to 
movement disorders after stroke i.e. paresis, stiffness and reflex modulation are related to 
functional outcome as determined by the Action Research Arm Test (ARAT) at 26 weeks 
after stroke. It is hypothesized that paresis, a high degree of stiffness and absence of reflex 
modulation will be related to poor functional outcome (chapter 6).
In the general discussion, the diverse aspects of measurement of impairment in arm-hand 
function after stroke are summarized, including clinical implications, methodological 
considerations and recommendations for future work (chapter 7).
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ABSTRACT
Background
Movement disorders after stroke are still captured by clinical gaze and translated to ordinal 
scores of low resolution. There is a clear need for objective quantification, with outcome 
measures related to pathophysiological background. Neural and non-neural contributors 
to joint behavior should be separated using different measurement conditions (tasks) and 
standardized input signals (force, position and velocity).
Methods
We reviewed recent literature for the application of biomechanical and/or elektro-
myographical (EMG) outcome measures under various measurement conditions in clinical 
research.
Results
Since 2005, 36 articles described the use of biomechanical and/or EMG outcome measures 
to quantify post-stroke movement disorder. Nineteen of the articles strived to separate 
neural and non-neural components. Only 6 of the articles measured biomechanical and 
EMG outcome measures simultaneously, while applying active and passive tasks and 
multiple velocities.
Conclusion
The distinction between neural and non-neural components to separately assess paresis, 
stiffness and muscle overactivity is not commonplace yet, while a large gap is to be bridged 
to attain reproducible and comparable results. Pathophysiologically clear concepts, 
substantiated with a comprehensive and concise measuring protocol will help professionals 
to identify and treat limiting factors in movement capabilities of post-stroke patients.
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INTRODUCTION
Movement disorders after stroke are the result of a complex interaction of primary neural 
damage and secondary tendomuscular changes [1,2]. The combination of paresis, stiffness 
and muscle overactivity leads to a phenotype that is easy to recognize clinically, but hard 
to quantify [1]. The broadly used term “spasticity” is under debate. Different definitions are 
used, and while it is mostly used as an umbrella-term for the phenotype, it describes only a 
part of the movement disorder [3-7], and has little relation to the capabilities of a patient to 
perform under different circumstances.
Clinical gaze and manual tests to assess movement disorder after stroke are readily available 
to every physician and are currently used as a basis for clinical practice. However, there 
are some difficulties in evaluating interventions within patients and between studies. For 
example, resolution of clinical tests is low, rater dependency is variable and conditions are 
difficult to standardize [8,9]. Little is known about responsiveness of the clinical tests to 
change. Ordinal scales are often misused as linear entities. Also, the measured construct 
of tests is not always taken into account when choosing a test for the assessment of stroke 
patients [9], i.e. improvement in tests on the domains of body structures and functions of the 
International Classification of Functioning, Disability and Health (ICF) do not automatically 
lead to improvement in the domains of activities and participation.
Correct use of a meaningful pathophysiological construct will enable clinicians to target 
their expensive and labor intensive therapies such as botulinum toxin and exercise programs 
more efficiently and effectively. Evidently, this challenges the community of rehabilitation 
specialists to quantify and objectify the components of movement disorders according to 
their pathophysiological origin [10,11] and their relevance for performance in the different 
ICF domains. For the domain of Body Structures and Body Functions this means that, first of 
all, input signals (e.g. velocity, force, angle) should be standardized to enable comparability 
and repeatability. Second multiple measuring conditions should be applied to trigger the 
different pathophysiological components [10,11], i.e. active tasks to study voluntary muscle 
properties, passive tasks to study passive tissue properties, and multiple measurement 
velocities to elicit stretch reflexive behavior. This will allow for differentiation in neural and 
non-neural components (see Table 1), and will enable clinicians to direct their therapies 
more precisely. Simultaneously used biomechanical and electrophysiological techniques 
can support the identification of active, passive and reflexive components and their 
complex (non linear) interactions.
Recommendations for objective and quantitative assessment of movement disorders 
after stroke are readily available [6,9,12,13]. However, it is unclear to which extent these 
recommendations are implemented in current research and clinical practice. The aim of 
the present paper is to provide an overview of biomechanical and electrophysiological 
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outcome measures recently used to describe post-stroke movement disorders. In addition, 
the use of underlying pathophysiological constructs is investigated.
METHODS
We conducted a literature search on PubMed and Web of Science with the following search 
terms: PubMed: stroke AND biomechanics AND electromyography (limits: last 5 year, 
human, adult) (accessed dec 2010). Web of Science: TS = ((stroke AND outcome measures) 
AND (biomechanic OR electromyography)). We also tracked references and citations. 
Thereafter we checked for doubles and scanned titles and abstracts. For a flow chart of the 
search, see Figure 1.
Figure 1 | Flow chart of the search strategy and outcome.
PubMed search:
47
Web of science search:
65








No biomechanical or 
electromyographical 
outcome measure
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Within the found references, we identified biomechanical and electromyographical 
(EMG) outcome measures, used in research on stroke patients. We searched for the 
pathophysiological construct of these outcome measures, given by the authors. 
Biomechanical and EMG outcome measures were examined for task instruction (active 
or passive) and for applied velocities of perturbations (slow, fast or multiple velocities). 
Subsequently, the outcome measures were separated in clusters, according to the applied 
method. For biomechanical outcome measures, the clusters were: range of motion, stiffness 
(or resistance to passive movement), maximum voluntary contraction, viscosity, work, 
mathematical models, other. For EMG outcome measures, the clusters were: magnitude, 
threshold (angle), onset (time), co-activation, other.
Table 1 | Division of components of post stroke movement disorder in non-neural and neural properties 
offers a construct for targeted therapy: an overview.
Measuring condition Construct
Non-neural Passive Stiffness, changed properties of connective tissue and joints
Neural Active Paresis, diminished voluntary muscular capacity
Reflexive (velocities) Muscle overactivity, stretch reflex behavior
RESULTS
The search yielded 37 articles. A flowchart of the search is illustrated in Figure 1. Study 
characteristics (measured segment, number of subjects, category of research) and the 
biomechanical and electrophysiological outcome measures found in each article, are 
summarized in Additional file 1.
Of the 37 articles, 3 were review articles [14-16]. In the other 34 articles, 30 included EMG 
outcome measures [17-45] and 31 included biomechanical outcome measures, while 25 
articles included both. Active and passive tasks were found in 10 articles [17,19,20,26,27,29,
33,34,38,46]. Different measuring velocities were found in 19 articles [18-22,24,27,30-35,37-
39,43,44,47]. In 6 articles, all of the aforementioned properties were present (see Figure 2) 
[19,20,27,33,34,38].
In 6 articles the biomechanical and/or EMG were used to evaluate treatment of stroke 
patients [17,26,28,31,37,43], 10 articles addressed reliability or feasibility of the outcome 
measures in stroke patients [20,21,23,32,35,44,45,47-49] and 18 articles were observational 
(difference between healthy subjects and stroke patients) or tested a new measuring 
method [18,19,22,24,25,27,29,30,33,34,36,38-42,46,50]. A total of 682 stroke patients and 
175 healthy subjects were included (see Additional file 1).
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In 25 articles the biomechanical and EMG techniques were used to objectify or quantify 
a clinical concept (e.g. spasticity, muscle tone, muscle activity, impairment or coupling) 
[18,20,22-27,29-33,35,37,39-47,50]. Alongside this, a large part of the articles use these 
techniques to separate the underlying (neural and non-neural) mechanisms of the concept 
(n = 19) [18-24,30,31,33-35,37,39,40,42-45]. Finally, there is also a small number of articles 
that advocate standardized input (n = 6) [19-21,24,30,40].
Biomechanical outcome measures
An overview of biomechanical outcome measures is presented in Additional file 1.
Range of motion was assessed as passive range of motion (pain-free or comfortable range 
of movement about a joint) (n = 12), active range of motion (n = 3) or both (n = 3). An 
electrogoniometer was used in 7 articles [17,18,22,25,35,46-48], customized devices were 
used in 8 articles [19,20,32,34,38,44,45,49] and in 2 articles manual goniometry was used to 
measure the range of motion [23,28].
Maximum voluntary contraction was measured with a handheld dynamometer 
(n = 1) [17], or a torque transducer/load cell in a (customized) device (n = 11) [19,27-
29,33,34,36,38,39,41,49]. Isometric conditions were applied in 11 articles, while in 1 article 
the peak active torque during flexion/extension movement was measured [19].
Stiffness or resistance to passive movement was measured as force or torque versus angle 
during passive movement, with the identical device as used for maximum voluntary 
contraction. The methods ranged from measuring peak resistance during movement 
(n = 2) [30,48], calculating the slope of the force-angle curve, linearized over a part 
[19,20,22,23,32,43] or the total [24,30,32,35,43] of the movement trajectory (n = 10), to a 
model fit (n = 5) [33,34,38,44,45]. A minority compared stiffness at different velocities (n = 5) 
[24,30,32,35,43].
Viscosity (n = 3) was derived from force and position at different velocities during passive 
movement [29,31,37]. Work (n = 2) was calculated as the area under the curve of moment-
angle, during passive movement [18,30]. Mathematical models (n = 3) were used to compare 
the estimated or predicted parameter with the actual parameter. This was done once for 
muscle length [27], once for torque [33] and once for angle trajectory [42].
Other biomechanical parameters assessed (n = 25) were tracking index (correlation between 
target angle and actual angle) [19,20], relaxation index (difference in angle between initial 
angle and first drop in pendulum test) [25], velocity dependent torque [18,33-35,44,45], 
phase dependent torque (timing of joint resistance compared to movement) [29,37], 
movement pattern (range of motion related to duration of phase) [46], miscellaneous other 
torque parameters [18,23,30,38,40,50] and gains [44,45]. Most attempted to cipher some 
spasticity parameter, using different combinations of velocities or positions and resulting 
torque.
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Electrophysiological outcome measures
All electrophysiological outcome measures were measured using surface electromyography 
(EMG). An overview of EMG outcome measures is presented in Additional file 1.
Magnitude of EMG signal was measured during maximum voluntary contraction (isometric) 
(n = 5) [27,28,33,39,41], with a target force or target EMG-level (n = 2) [27,39], during passive 
movement (n = 18) [17-20,22-26,30,33,36,38,40,43,44,46] or during active movement [46]. 
Tendon taps were used in 2 articles [23,40] and H-reflex stimulation were used in 2 articles 
[26,36]. In all cases the EMG was rectified and/or normalized. The EMG activity during 
maximum voluntary contraction was mostly used as a reference value for the magnitude of 
reflex EMG response. In 6 cases, EMG activation was compared between different velocities 
or task instructions [22,30,35,39,43,46].
Threshold was described as the angle at which EMG activity started during passive 
movement. Thresholds were compared between different velocities of perturbation 
[21,30,31,37]. Onset was described as the latency in time between start of perturbation and 
start of EMG activity [27,33,34,38,45].
Co-activation (or cocontraction) compared agonistic and antagonistic EMG-activity during 
passive movement (n = 4) [19,20,44,45], during active movement (n = 1) [46] or maximum 
voluntary contraction (n = 1)[34].
Other parameters of EMG (n = 9) that were assessed, include velocity dependent EMG signal 
[35], tonic threshold (extrapolation of thresholds from different velocities to zero velocity) 
[21], duration of activity [29], modulation of activity [29], volitional response time [27,39], 
slope of recruitment curve and H-reflex related parameters [36].
Pathophysiological construct of outcome measures
Observed pathophysiological constructs were spasticity (n = 16) [17,21-26,32,33,35,37,44-
48], muscle tone [18,30,31,42,43], muscle overactivity [28,39,40,50], paresis [49], motor 
control [29], impairment [19,20], coupling between extremities [27,36,38], secondary 
changes [34] and normalization of signals [41]. Observed underlying mechanisms used 
to underpin the pathophysiological constructs were paresis [17,19-21,24,34,49], limited 
range of motion [19,20,46,50], stiffness/hypertonia [18-25,30-35,37,38,42-45,47,50], muscle 
overactivity/hyperreflexia [17,20-25,27-31,34-40,43,45,50] and motor control/dexterity 
[19,20,29,33,46,49]. An overview of the cross-links between observed pathophysiological 
constructs and underlying mechanisms is presented in Table 2.
The most addressed concept was that of spasticity (n = 16), although different definitions 
and interpretations were given [17,21-26,32,33,35,37,44-48]. The observed underlying 
mechanism was in either non-neural (stiffness, resistance) (n = 4) [32,33,45,47], neural 
(muscle overactivity, hyperreflexia) (n = 2) [17,46], or a combination (n = 8) [21-25,35,37,45]. 
The remaining articles concerning the concept of spasticity did not discriminate between 
neural and non-neural components (n = 2) [26,48].
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The second most addressed concept was that of muscle tone (n = 5) [18,30,31,42,43]. All five 
use non-neural components of muscle tone as underlying mechanism (i.e. stiffness, inertia, 
mechanical characteristics of passive tendomuscular and connective tissue, mechanical 
characteristics of activated muscle), while neural components (muscle overactivity, 
hyperreflexia) were separately addressed in 3 articles [30,31,43].
The concept of muscle overactivity was the main topic in 4 articles [28,39,40,50]. two articles 
distinguish between neural and non-neural properties (n = 2) [39,40].
The underlying mechanisms of stiffness and muscle overactivity were combined in 15 out 
of the 37 articles [19,21-25,30,31,34,35,37,38,40,43,45].
Table 2 | Concepts and pathophysiological mechanisms categorized in articles measuring movement 
disorder after stroke.



























































Spasticity 16 3 2 12 9 2
Muscle tone or hypertonia 5 0 0 5 3 0
Muscle overactivity 4* 0 1 1 4 0
Other
paresis 1 1 0 0 0 1
motor control 1 0 0 0 1 1
impairment 2 2 2 2 1 2
coupling 3# 0 0 1 3 0
secondary changes 1 1 0 1 1 0
normalization 1 0 0 0 0 0
*muscle overactivity (n = 2), reflex response (n = 2); # affected & non affected side (n = 1), upper & lower extremity (n = 1), proximal 
& distal segment of extremity (n = 1).
DISCUSSION
Since 2005, 37 articles described the use of biomechanical and/or EMG outcome measures 
to describe post-stroke movement disorder. Nineteen of the articles strived to separate 
neural from non-neural components. The most frequent pathophysiological constructs 
were spasticity, muscle tone and muscle overactivity. Only 6 of the articles measure 
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biomechanical and EMG outcome measures simultaneously, while applying active and 
passive tasks and multiple velocities.
Whilst this study limited the use of search engines to PubMed and Web of Science, it is 
likely that the main bulk of relevant literature is identified by using generic search terms and 
cross-checking references. The restriction to search only recent literature is justified by the 
specific aim of the study, namely, to identify current methods.
This review shows that in recent years initiatives have been taken to quantify and objectify 
measurements in post stroke movement disorders. It also indicates that the conceptual 
mainframe of separating movement disorder into neural and non-neural components was 
not always taken into account, i.e. active, passive and reflex contributions were not always 
divided. In some articles, there was a lack of consistency in administration of the underlying 
pathophysiological mechanism (paresis, increased stiffness and muscle overactivity) or 
pathophysiological concept (spasticity, muscle tone). For example: one [50] of the 4 papers 
on muscle overactivity did not use EMG. Another example is spasticity, which was described 
as velocity dependent in 13 of the 16 papers [17,21,23-26,32,33,35,44,45,47,48], while only 8 
of the 16 papers use multiple velocities in their tests [21,22,24,32,33,35,37,47].
Measuring in different operating points is not commonplace yet, while it will allow for a 
more complete understanding of the capabilities of a patient with a movement disorder. 
Active and passive tasks instructions will give information about paresis and involuntary 
muscle activity, and a variation of velocities of perturbations will illuminate stiffness and 
reflex contributions. A more specific knowledge of the capabilities of a patient will probably 
lead to a more specific treatment. For example, patients with movement disorder due to 
severe paresis or reduced range of motion through secondary changes will not benefit 
from spasmolytic or neurolytic treatment. Yet, before treatment in spastic patients, these 
disorders are not systematically separated from muscle overactivity. This does not benefit 
the individual patient, is not cost effective and will introduce a bias in research of effect 
measurements after treatment.
The techniques as described in this review are mostly not available in clinical practice yet. 
This has led to prolonged use of clinical scores, despite their known disadvantages. We 
recommend that future work on movement disorder in stroke patients should be based 
on a clear concept and include a comprehensive and concise measurement protocol 
which is easily applied on and well tolerated by stroke patients. Outcome measures 
should be pathophysiologically meaningful and applicable in decision making for 
clinicians. Additionally, to increase the understanding of primary and secondary changes, 
longitudinal studies will be essential [51]. This will enable specialists in physical medicine 
and rehabilitation to tailor their therapies and, moreover, allow them to assess the effect of 
(experimental) interventions.
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Figure 2 | Number of articles conforming to recommendations for measuring movement disorder 














In the last 6 years a number of initiatives were developed to quantify and objectify movement 
disorder after stroke. However, the distinction between non-neural and neural components 
to separately assess paresis, stiffness and muscle overactivity, is not commonplace yet. A 
large gap has to be bridged to attain reproducible and comparable results.
Pathophysiologically clear concepts, substantiated with a comprehensive and concise 
measuring protocol will help professionals to identify and treat limiting factors in movement 
capabilities of post-stroke patients.




H-reflex: Hoffmann reflex, EMG response of muscle after electrical stimulation of the 
afferent nerve fibers; 
EXPLICIT-stroke: “EXplaining PLastICITy after stroke”;
mAS: Modified Ashworth Score; 
ICF: The International Classification of Functioning, Disability and Health is a classification 
of health and health-related domains. These domains are classified from body, individual 
and societal perspectives by means of two lists: a list of body functions and structure, 
and a list of domains of activity and participation. Since an individual’s functioning and 
disability occurs in a context, the ICF also includes a list of environmental factors [www.
who.int accessed May 6th 2011].
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ABSTRACT
Functional recovery post stroke is determined by a complex interplay of neural and 
mechanical (muscular/ tissue) changes. In the present paper, we elaborate on a 
methodology to assess neuromechanical joint properties in a comprehensive and concise 
way. A measurement protocol applicable to the wrist joint is introduced and outcome is 
described for illustrative purposes. 
By means of a single axis manipulator, a variety of conditions are applied including different 
exerted loadings and a passive or active task instruction. The combination of different 
tasks and loadings systematically excites the nonlinear neuromechanical joint system. 
Output of the joint system is measured in terms of torques, angular rotation and muscle 
activation. Both signal analysis and system identification methods are applied to translate 
the measured variables into physiologically meaningful parameters, describing passive and 
active (muscle) tissue properties and reflexive characteristics.
A severely impaired and a well-recovered stroke patient show clear differences in outcome 
parameters. Furthermore, parameters are shown to change over condition, indicating 
that multiple conditions need to be applied to identify their potentially varying role in 
movement disorders. The protocol is used in a longitudinal study to explore post-stroke 
upper limb recovery mechanisms, i.e. the EXPLICIT-stroke study.
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INTRODUCTION
Movement disorders after stroke may have a major impact on daily life. Almost two thirds 
of the stroke survivors suffer from sustained deterioration of arm-hand function which 
threatens physical independency [1]. Besides cortical and corticospinal tract integrity, 
functional movement and motor deficits are largely determined by joint neuromechanics.
In the acute phase after stroke, mechanical behaviour at joint level is characterized by 
flaccidity and paresis, while in the sub acute phase, signs of muscle over-activity and joint 
stiffening become more prominent [2,3]. Although this is a common recovery pattern, 
several different phenotypes may develop in the chronic phase [4]. These phenotypes will 
be the result of a complex and varying interplay between neurological and biomechanical 
changes over time. A better understanding of the interplay and changing contributions of 
aforementioned neuromechanical processes to movement disorders is needed to address 
the full functional recovery potential. The EXPLICIT-stroke (EXplaining PLastICITy after 
stroke) study was designed to explore the functional impact of the time-dependent changes 
in cortical neuroplasticity and neuromechanics, as well as the adaptive compensation 
strategies that are applied to cope with ischemic brain lesion related motor deficits [5].
Current clinical assessment of joint neuromechanics is restricted to ordinal rating scales 
such as the Medical Research Council scale for muscle force, goniometry for impaired 
range of motion (ROM) and Ashworth score for spasticity. The latter however, is incapable 
of discriminating between the possible neural and/or mechanical sources of increased 
joint resistance [4,6,7]. The use of robotics (e.g. a wrist manipulator) to evoke controlled 
force and torque perturbations, electromyography (EMG) to record muscle activity and 
neuromuscular modelling potentially allows for an individual assessment of neurological 
and biomechanical joint properties [6,8-11].
Nonlinear dynamics of the neuromuscular system greatly influence joint behaviour, yet their 
role has not been fully recognised. For example, the stretching of tissue yields nonlinear 
force curves: twice as much stretching does not result in twice as much resistance of the joint 
[12]. Another example is the sensitivity of the stretch reflexes, which may be modulated at 
spinal cord level [13]. While linear mass-spring-damper-like concepts are far easier to apply 
and are regularly used to simplify mechanical behaviour, they do not comprehensively 
describe biomechanical properties of the joint under different environmental conditions 
(tasks and loadings). Using prior knowledge of nonlinearities, the joint can be conditioned 
such that the nonlinear dynamics of the neuromuscular system can be accounted for, or 
even parameterized. 
In this paper we present the methodological aspects on how to individually address the 
different properties of the (nonlinear) neurological and biomechanical components of wrist 
joint behaviour in during flexion-extension movement. This resulted in a comprehensive 
and clinically applicable assessment protocol. Longitudinal measurements with this specific 
34 | Chapter 3
protocol, within a longitudinal measurement framework such as the EXPLICIT-stroke study, 
will enhance our knowledge of primary and secondary changes in neuromechanics when 
functional changes are observed. 
METHODS I. LINE OF THOUGHT
Assessment of neurological and biomechanical contributors to movement disorders after 
stroke should result in structure specific parameters that are potentially modifiable by 
therapeutic intervention. Treatment is commonly aimed at muscle activation or strength 
in case of paresis, reduction of reflex sensitivity or neural input in case of hyperreflexia 
or the stretching of passive tissue in case of joint stiffening. Therefore, we define the 
neuromechanical system on a therapeutically attainable level into passive, active and 
reflexive torque components: 
 – Passive = all joint resistance observed when no neural input is fed to the muscles
 – Active = muscle torque generation due to neural input (supraspinal and reflexive)
 – Reflexive = active muscle torque solely due to proprioceptive feedback
The interconnection between passive, active and reflexive contributors is represented 
in Figure 1. By differentiating the contributions of each of these elements to joint level 
mechanics, their individual roles in movement disorders can be better defined, allowing for 
targeted therapy. 
In order to characterize the phenotype of post-stroke patients properly, the neuromechanical 
system needs to be sufficiently triggered i.e. different conditions need to be applied. 
Passive, active and reflexive components will be dependent on the state of the wrist (i.e. 
joint torque, joint angle and muscle activity) and the externally applied loading. The state 
represents the current operating point of the system and subsequently its dynamical 
properties, observed at endpoint level in torque (and angle). A haptic wrist manipulator 
combined with electromyographic (EMG) measurement is an easy-to-use combination of 
tools that allows for applying angle or torque controlled perturbations and the subsequent 
assessment of changes in joint state. The different modes in combination with task 
instruction enable us to impose a desired state. Properties of passive, active and reflexive 
contributors can be estimated from the measured in- and output data. When torque is the 
input, angular displacement is the output and vice-versa. Output signals including EMG, as 
a representative of active muscle state, may also be used to inform the subject on actual 
task performance. 
For analysis, we define two different approaches. The first approach will be referred to as 
signal analysis. This approach aims to induce large variations regarding the role of model 
components by applying specific conditions to the system. Slow movements will exclude 
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reflexive activity, while the amount of voluntary contraction can be modulated, and therefore 
controlled, by proper task instruction. This gives contributor-specific tests that aim to assess 
passive, active or reflexive contributors individually. The second approach, referred to as 
system identification, is based on the fact that reflexive resistance is dynamically different 
from passive or active resistance. Differentiation between the feedback pathways can be 
done using torque-angle correlation analysis, keeping the closed loop configuration of 
reflexive (neural) and muscular (mechanical) components into account. Both approaches 
make it possible to express system performance in terms of its underlying properties, yet 
conditions are significantly different. System identification methods are not yet sophisticated 
enough to perform well over a nonlinear domain, and additional signal analysis methods are 
still needed. Furthermore, limit behaviour, such as ROM or maximal voluntary contraction 
(MVC), is easier to assess using basic signal analysis. The following subsections describe a 
listing of interesting outcomes that together result in a comprehensive set for assessment 
of joint neuromechanics. These outcomes were used as a basis for the protocol discussed in 
the following section, i.e., “The EXPLICIT-stroke protocol”.
Signal analysis
Passive tests (slow movement while instructed to “do nothing”)
Of functional interest are the ROM and the resistance that subjects experience when their 
joint is moved passively through the ROM. The equilibrium angle of the joint, or rest angle 
represents a stiffness balance between agonist and antagonistic muscles. Passive tests aim 
to assess the passive joint structures in subjects, as given in Figure 1. For the assessment of 
the passive structures, subjects are instructed to do nothing. Movement of the wrist at a 
slow velocity then results in stretching of passive tissues, while minimizing the contribution 
of active muscle contraction and reflexive activity. The resulting joint torque will be the 
result of the stiffness and viscosity arising from predominantly passive contractile and 
non-contractile tissue. EMG measurements should be used to check for interfering muscle 
activation during measurement and for data analysis. The following outcomes can be listed 
for passive tasks:
 – responsive range of motion
 – stiffness and damping 
 – rest angle (angle of joint flexion-extension torque equilibrium)
In stroke patients, relative to controls, we expect restrictions in ROM, higher joint stiffness 
and a rest angle that tends towards flexion [2].
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Figure 1 | Simplified graphical model of the components of the wrist joint, depicted with active, 
passive and reflexive elements, corresponding with areas for target therapy.
Dotted lines indicate non-invasively measurable connections, EMG (left), torque (center) and rotation (right). Rotation includes 






















Active tests (slow movement while instructed to “move / push / resist”) 
These tests address the ability of the patient to actively generate torque at the joint level, 
preferably in a controlled manner (Figure 1). Applied torque levels should exceed resistance 
of passive tissue or antagonistic muscles. A subject’s ability to generate this particular torque 
level can be easily tested (also in the clinic) by asking them to flex or extend maximally (i.e. 
the active ROM). Alternative active tests are performed in a standard position (i.e. the rest 
angle) or during imposed slow movement to minimize reflex activity. Subjects are provided 
with visual feedback on their actual task performance. Joint angle (relating to overlap of 
muscle filaments and muscle moment arm, tissue strain) and joint velocity (relating to cross-
bridge turnover dynamics and tissue viscosity) also contribute to the potential production 
of joint torque [14]. Applying an active and a passive test in similar test conditions, defined 
in terms of joint angle and angular velocity, allows for subtraction of torques generated by 
the passive structures from the data, under the assumption that the active muscle does not 
influence stiffness/viscosity values of surrounding passive structures. 
From these measurements the following outcomes can be listed for active tasks:
 – self induced ROM
 – control over joint torque build-up (i.e. quality of motor control)
 – maximally attainable torque
 – angular/velocity dependent joint torque production
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In stroke patients, relative to controls, we expect a smaller self induced ROM, a lower 
maximally attainable joint torque and less control over joint torque. Furthermore, it is 
expected that angular-dependency of torque production increases, with an optimum angle 
(e.g. muscle filament overlap) tending more towards flexion [15]. 
Reflexive tests (fast movement)
Reflexive tests are aimed to assess the reflexive pathways, as given in Figure 1. Higher 
reflex activity is known to be triggered by high joint angular velocity [11] and together 
with reflexive time delay (loop-time) it is considered to play an important role in reflex loop 
stability. To measure the reflexes we commonly use EMG recordings together with controlled, 
repeated perturbations. This will deliver reproducible data on reflexively triggered muscle 
activity (e.g. short and long latency reflexes). Perturbations are to be applied at random 
intervals to minimize anticipation (as subjects can influence their reflexive sensitivity, 
i.e. reflex modulation). Note however that active components should also be considered 
when assessing reflexive activity, as functional impairment is defined by the level of joint 
resistance. In signal analysis methods the possibilities are limited, because the dynamics 
of reflexively activated muscle are often difficult to distinguish from passive resistance, 
especially when reflexive activity is small or quickly occurring after perturbation. Clinical 
measures for spasticity include sudden increase in resistance or EMG and the angle at which 
this increase occurs, during movement through the ROM (i.e. threshold angle). 
These conditions result in the following reflex-related outcomes:
 – reflex loop-time (short and long latency reflex time)
 – reflex magnitude (e.g. area under normalized EMG response)
 – reflexively induced joint torque
 – threshold angle
In stroke patients, relative to controls, we expect a longer short-latency reflex time, a 
stronger influence of reflex activity on joint resistance, and a threshold angle located more 
towards the flexion side of the ROM.
System Identification
These tests aim at measuring the full joint dynamics in an integral way, while taking the 
closed loop relation into account. Particular interest lies with the reflexive contributions 
to joint torque. Continuous random small amplitude torque perturbations induce high 
velocities and have been proven to allow for the quantification of intrinsic and reflexive 
components during either a passive or an active (postural control) task [5]. Based on these 
experiments, active modulation of the reflexive feedback gains, e.g. presynaptic inhibition 
on muscle spindles and Golgi tendon organs sensory feedback, have been studied using 
simple linear models. Different signal types include multisines and continuous ramp and 
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hold like perturbations such as ramped block waves or pseudo-random binary sequences. 
Still the effect of nonlinearity on measurement is unknown and may change over type of 
perturbation. Clear findings from the wide bandwidth multisine studies were that reflex 
gains increased with an active task and with the amount of damping provided by the 
environment.
These integral tests result in the following outcomes:
 – stiffness and damping (of passive plus active structures)
 – reflex loop time
 – reflex magnitude (also referred to as reflex gain: torque contribution to joint dynamics)
 – reflex modulation
In stroke patients we expect an increased short-latency reflex time, a stronger influence of 
reflex activity on joint resistance, higher reflex gains, smaller differences between active and 
passive tasks and less modulation with increase in external damping.
METHODS II. A COMPREHENSIVE NEUROMECHANICAL 
ASSESSMENT PROTOCOL
A protocol has been set up that assesses passive, active and reflexive components under 
different conditions, according to the aforementioned line of thought. This protocol is used 
in the EXPLICIT-stroke study, which aims to assess the relation between primary neural 
recover and behavioral compensation strategies in arm function recovery after stroke. 
The measurement set-up comprises a haptic manipulator and EMG-system (Appendix I). 
Specifications of the set-up have also been validated by Grimaldi et al. [16]. The protocol 
consists of multiple tests, all of which are either instrumented versions of tests from the 
clinic or have been tested previously tested on different setups, e.g. Schuurmans et al. [17] 
on analysis of the reflexive pathway (neural looptime test) and van der Helm et al. [18] and 
Meskers et al. [19] (amongst others) on multisine perturbations combined with system 
identification methods. The described neuromechanical protocol uses a combination of 
tests that all contribute to a post-stroke patient specific signature, and is new in extensively 
measuring both the structural and functional side of neuromechanical recovery.
Measurement protocol
The measurement protocol starts with tests which also provide the safety boundaries for 
later tests (ROM) or feedback target (MVC, restangle). Most tests are applied twice, one 
for the flexor carpi radialis (FCR) and one for extensor carpi radialis (ECR) muscle activity. 
Visual feedback of force, position or EMG is provided depending on the task instruction. For 
maximal active tasks, visual feedback is provided to increase subject motivation. Displayed 
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EMG levels are rectified and averaged over half a second (refresh rate 16Hz). Subjects 
are allowed to practice. To prevent fatigue, resting time is provided between tests. Total 
measuring time is approximately 45 min (including instructions and practice; excluding 
EMG placement). A full list of used tests and their properties is also given in Table 1. The 
analysis of each test is outlined below. After the title of each test an abbreviation is given 
that refers to the corresponding row in Table 1.
Passive tests (slow movement while instructed to “do nothing”)
1. Range Of Motion Passive – ROMP (PROM) 
Applied torques systematically vary between -2 and 2Nm. Movement is smoothed by 
keeping the torque derivative to time low for small torques. The PROM parameter is obtained 
by taking the difference between the minimal and maximal angle during the ROM test, as 
given in Figure 2 (left). 
2. Stiffness In Rest – SIR (PRA, Pk and Pd)
After obtaining the PROM, position controlled movement is allowed. The stiffness in rest is 
tested with a constant velocity, position controlled perturbation. Movement is performed in 
two directions, resulting in a hysteresis curve [8,20], as shown in Figure 3. The defined angle 
of rest PRA is taken as the angle where the average hysteresis curve per angle crosses 0Nm 
(hence assuming linear damping for small positive and negative velocities). The stiffness 
and damping related parameters (Pk and Pd) are, respectively, the average negative tangent 
and the average difference of the hysteresis curve over 0.2 rad around the rest angle (Figure 
3), divided by the difference in velocity (0.2 rad/s). The latter will approximate the actual 
damping if stiffness in both movement directions is equal. 
Active tests (slow movement while instructed to “move / push / resist”) 
3. Range Of Motion Active – ROMA (AROM) 
For the ROMA test, the Wristalyzer was set to a nonresistant mode. The subject was asked 
to show his or her maximal ROM. Analysis of the AROM parameter equals the analysis of PROM 
parameter, given in Figure 2 (right). 
4. Maximal Voluntary Contraction – MVC (AMVC) 
A magnetic break was set and the subject was asked to contract maximally. Torque data was 
filtered with a 3rd order Butterworth filter of 20 Hz to reduce the influence of measurement 
noise. AMVC is the maximum measured torque over two repetitions. For clarity, only one 
dataset (including the AMVC) out of two repetitions has been shown in Figure 4.
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Table 1 | Test specifications of the tests in the EXPLICIT-stroke protocol including: task instruction, 
visual feedback to the patient Wristalyzer controller mode (WA), Wristalyzer controller reference signal 
and resulting outcome parameters.
Test Task Visual feedback WA WA Reference signal Parameter
ROMP passive none Torque slow increase, max 2 Nm PROM
SIR passive none Angle ramp 0.1 rad/s through full 
ROM
Pk Pd
passive none Angle ramp 0.1 rad/s through full 
ROM
PRA
ROMA active: maximal 
angular excursion
attained angles and 
current angle
Torque free (zero torque) AROM
MVC active: push max attained torque and 
current torque 
Angle brake AMVC
CJT active: push Increasing torque  
target: ramp 1Nm/s
Angle brake ACJT
ASH passive none Angle ramp 1 sec through full ROM Rta
passive none Angle ramp 0.5 sec through full 
ROM
Rta.5
NL passive none Angle ramp and hold, speed 4 rad/s, 
amplitude 0.14 rad
Rlt
active: push  
(const. EMG)
EMG target level  
10% MVC EMG
Angle ramp and hold, speed 4 rad/s, 
amplitude 0.14 rad
Rlt
WB active: hold  
position
Reference angle  
incl. history 
Torque crested multisine 0.3-50 Hz Pb_st, Pk_st, 
Rkv_st, Rtd_st
passive none (EMG for 
researcher)
Torque crested multisine 0.3-50 Hz Pb_sl, Pk_sl, 
Rkv_sl, Rtd_sl
active: hold  
position
Reference angle incl. 
history 
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Figure 2 | Range of motion data for patient A (light grey, solid —) and B (dark grey, dashed ---). Passive 
ROM (PROM, left) and active ROM (AROM, right) are indicated with thick horizontal lines.





























Figure 3 | Stiffness in rest test result for patient A (light grey, solid —) and patient B (dark grey, dashed 
---). Thick lines around zero (left figure) indicate average slope of the data at those angles (Pk) and 
intervals around zero (right figure) show the (Pd).


































5. Control over Joint Torque – CJT (ACJT) 
The Control over Joint Torque (CJT) test is added to address the quality of motor control of 
the subject. The magnetic break was applied and the subject was asked to steadily increase 
his or her level of contraction (1Nm/s). Torque data was again filtered for analysis with a 
3rd order Butterworth filter of 20 Hz to reduce influences measurement noise. The level at 
which the patient fails to follow the reference torque (ACJT) is determined by the point at 
which the patient generated torque is lower than 1Nm under the reference torque (circle in 
Figure 5). The maximal force during the test (thick horizontal line in Figure 5) is used as an 
upper boundary for ACJT.
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Figure 4 | Maximal voluntary contraction data for patient A (light grey, solid —) and patient B (dark 
grey, dashed ---). Flexion MVC (AMVC, left) and extension MVC (AMVC, right) are indicated with thick 
horizontal lines.






























Figure 5 | Control over Joint Torque data ACJT for patient A (light grey, solid —) and patient B (dark 
grey, dashed ---), for extension (left) and flexion (right). The diagonal straight solid line indicates the 
reference force over time, the diagonal dashed line shows the maximal follow lag. Circles indicate 
where the patient fails to follow the reference torque; parameters ACJT for patient B are indicated with 
a cross.






















Reflexive tests (fast movement)
6. Ashworth-ASH (Rta and Rta.5) 
An instrumented version of the clinical modified Ashworth test has been included in the 
protocol to address the reflexive system. The Ashworth test gives insight into the reflexive 
properties during a large sweep trough the ROM. Moreover, it allows for validation of the 
use of an Ashworth test in the clinic. 
For the analysis, the EMG signal is rectified and filtered with a 3rd order low pass Butterworth 
filter of 80Hz. We first determined the angle for which the EMG signal exceeds 5 times 
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the standard deviation of the background EMG (horizontal dotted line in Figure 6). The 
preceding point where the EMG signal exceeds 2.81 times the standard deviation (i.e. 
resulting in 0.25% probability of being background signal if normally distributed) is taken as 
the onset of the EMG response to the perturbation. The corresponding angle at that onset 
time is the threshold angle (Rta).
7. Neural Looptime-NL (Rlt and Rauc_M1) 
The neural looptime tests consist of nine ramp (2 rad/s) and hold (0.75s) perturbations that 
occur at random time intervals. After the hold phase a returning phase using a minimal jerk 
profile is initiated. For the analysis, the data of each of the runs is averaged over the nine 
perturbations to reduce noise. This sequence is performed in a passive and active condition; 
first the subject is asked to relax, second to push against the handle with constant EMG at 
10% of measured MVC EMG. For the latter rectified and filtered EMG (averaging 8 times/sec) 
is shown to the subject as a vertical bar with a target area at 10+/-2.5% for the stretched 
muscle. Color of the bar changed from red to green when entering the target area. Subjects 
were instructed to ignore perturbations as much as possible and to return to the target area 
after perturbations, when necessary. Figure 7 shows the resulting average EMG signal with 
its cross-trial standard deviation. The EMG signal is rectified and filtered with a 3rd order low 
pass Butterworth filter of 80Hz. The base level (BL) of the EMG is determined as the average 
EMG over the time window [-400,-20]ms with respect to the start of the perturbation [17]. 
The EMG signal E is then normalized to the signal En using the baselevel BL:
En(t) = E (t)/BL – 1
Reflexive EMG response to the input stretch is assumed to be significant if the signal exceeds 
2.81 times the standard deviation of the baselevel, indicated with the horizontal dotted 
line in Figure 7. The short-latency reflex onset Rlt and area under the curve Rauc_M1 are then 
obtained (time window for both parameters limited to [20, 50] ms, with respect to pulse 
onset [17]). 
System Identification
8. Multisine perturbations-WB (Pk, Pd, Rtd, Rkv_st, Ak_act, Ad_act, Rrm_act and Rrm_env) 
A set of multisine perturbations has been added to address the subjects capabilities in 
disturbance rejection and adaptation to a changing environment (increased damping). 
Multisine perturbations represent a functional disturbance and may be supported by 
findings from the neural looptime test. 
Possible low frequent compensational behavior of the patient (against drift away from 
the target angle), will be corrected for by first pre-filtering the raw data using a 3rd order 
butterworth high pass filter of 1 Hz. A frequency response function (FRF) is then estimated 
using a closed loop estimator on the pre-filtered data, 
44 | Chapter 3
HFRF = Sda/SdT
Where Sda and SdT are the estimated cross spectral densities of the externally applied 
disturbance torque d with the measured angle a and interaction torque T, using a Fast 
Fourier Transform [18]. 
Figure 6 | Ashworth data of patient A (left) and patient B (right). 
Measured FCR EMG data (dark solid lines —), 2.81 times the standard deviation of the background (dashed lines ---) and the 
derivation of the threshold angle parameter Rta (dashed-dotted lines -.-.) are shown. Both figures represent the condition of 1ROM/





































Figure 7 | Neural looptime test datasets for patient A (left) and patient B (right). 
Average and standard deviation of nine FCR EMG responses (mean: dashed line ---, standard deviation: grey surrounding surface) 
and corresponding analysis interval and values (Rlt: circle O and RAUC: surface under --- within the indicated interval [0.02 – 0.05] 
sec). Dotted line (···) indicates the 2.81 times the standard deviation of the background EMG.
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The resulting FRF is then averaged in groups of 8 frequency points to improve the estimate. 
Finally, a model [18,19], based on the block scheme depicted in Figure 1 is fitted to the 
acquired FRF (Figure 8). Inertia, spring (Pk_<condition>), damper (Pd_<condition>), eigenfrequency of 
muscle activation, velocity dependent reflex gain (Rkv_<condition>), reflex speed (Rtd_<condition>) 
and grip dynamics parameters are all included in the model [18]. Different types of 
reflexive feedback (position, velocity and force) were tested, yet only velocity feedback 
gave low parameter variability, in accordance with earlier results of Meskers et al. [19]. 
Microneurographic studies imply velocity feedback is muscle spindle feedback, as opposed 
to Golgi Tendon Organ feedback [21]. Using different conditions (stiff, slack and damp, see 
Table 3) the changes of the system over condition can be investigated. The difference in 
stiffness and damping between passive and active conditions yields the activation induced 
stiffness and damping Ak_act, Ad_act:
Ak_act = Ak_st – Ak_sl 
Ad_act = Ad_st – Ad_sl
Difference in reflex gain over conditions results in the modulation parameters Rrm_act and 
Rrm_env:
Rrm_act = Rkv_st – Rkv_sl 
Rrm_env = Rkv_da – Rkv_st
RESULTS
Parameter values taken from two stroke patients are given in Table 2 and 3, for illustration 
purposes. Both patients A and B are female (aged 55 and 45, respectively) and were 
measured more than one year post-stroke. Ashworth scores for the measured and impaired 
left wrist joint of both patients were manually determined to be 3 and 0 respectively.
Passive parameters
Patient A shows a smaller passive ROM (PROM) and an increased stiffness (Pk) and viscosity 
(Pd) at the restangle, both for large and small perturbations, as shown in Table 2 and 3, 
respectively. This indicates a higher resistance against movement from passive structures, 
as muscle activation is checked for using EMG. Differences between Table 2 and Table 3 
values are expected as they differ greatly in condition. The data underlying the system 
identification method contains only small angular deviations, while the data underlying 
the signal analysis is performed during a long sweep through the ROM. Earlier research on 
passive stiffness has shown that in the initial phase of movement the stiffness is larger [12]. 
Furthermore, the rest angle (PRA) of patient A is located more towards flexion (Table 2). It is 
known that in the sub-acute phase the restangle moves towards flexion [2].
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Figure 8 | Bode magnitude plot of multisine-test data from patient A (left) and B (right). 
Bode magnitude representation of the model fits of the data for the 3 measurement conditions: stiff (fit: dotted ···, FRF estimate: *), 





































In Table 2, the combination of a decreased active ROM (AROM) and a low MVC (AMVC) is 
seen in the resulting parameters of patient A. Movement is determined by a both the 
potential voluntary torque and the stiffness of the joint, for each angle. Therefore we can 
expect a smaller value for the AROM parameter given low voluntary contraction (e.g. AMVC 
in the restangle) and stiffness of passive structures (e.g. Pk in the restangle). Control over 
Joint Torque (ACJT) values show the amount of joint torque control in a slowly increasing 
tracking task. ACJT values are expected to be slightly lower than the MVC and are found to 
be approximately 60 % of the MVC value for patient B. The ACJT is set to zero for patient A as 
the maximal force in test does not exceed 1Nm (see appendix II for more details on analysis). 
Table 3 coincidentally shows equal values for stiffness (Ak_act) and damping (Ad_act), induced 
by the “hold position” task instruction. This shows that both patients were able to increase 
their joint stiffness voluntarily, yet the control over the unilaterally produced joint torque 
(ACJT) is a lot lower for patient A.
Reflexive parameters
The reflex loop time (Rlt) of about 23 ms is comparable to the values found in literature [17]. 
The higher value for patient A was due to low reflexive activity for that condition (Rm1_auc). 
The looptime parameter resulting from the system identification procedure (Table 3, Rtd_st) 
is generally higher. This difference is expected to be of methodological nature; for system 
identification procedures the best fit may lie more towards the long latency response, in 
stead of the short latency response onset. Still, the two are assumed to be equal in their 
physiological background and do not yield additional information. For patient B the area 
under the curve Rm1_auc is similar for FCR and ECR. The Rm1_auc value for the ECR of patient A 
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is substantially lower than the other values, indicating a very small reflex, if at all present. 
The FCR muscle shows a very high response, possibly indicating hyperreflexia. Additional 
looptime (Rlt) and reflexive activity (Rauc_m1) are believed to contribute to joint instability. 
Threshold angles (Rta) are similar for both patient A and B (the flexion angle prior to 
movement is with 85 degrees also equal for both patients, see PROM, Table 1). The angular 
velocities at which these were determined differ significantly (72deg/sec and 135deg/sec 
for patient A and B, respectively), which, as reflexes are velocity dependent, explains the 
quick response of the more recovered subject. Threshold angles are only given for the FCR 
muscle as the stretching of the ECR muscle did not result in reflexive activation. Reflexive 
contributions to joint resistance (Rkv_stiff) are stronger in patient B. For both patients activation 
of the muscles has a large influence on the modulation of reflexes (Rrm_act). Furthermore, a 
more stable, damped environment does not trigger reflex modulation (Rrm_env) for patient A 
and unexpectedly [19] causes negative reflex modulation for patient B.
Table 2 | Parameters following from the signal analysis technique tested on a paretic chronic stroke 
patient (pt. A) and a functionally recovered chronic stroke patient (pt. B). 
E refers to Extension and F to Flexion. All angles, except for ROM parameters, are given in degrees from the zero angle of the 
Wristalyzer.
Parameter Patient A Patient B
Passive
ROM Passive PROM 72 deg  
[13,6 – 85,1]
135 deg  
[-46,9 – 87,7]
Rest angle PRA 53 deg flexion 34 deg flexion
Active
ROM Active AROM 17 deg  
[49,1 – 65,9]
126 deg  
[-38,1 – 87,7]
Maximal Voluntary Contraction (MVC) at rest angle AMVC F: 1,2 Nm  
E: 1,3 Nm
F: 9,5 Nm  
E: 6,2 Nm
Control over Joint Torque (CJT) ACJT F: 0 Nm  
E: 0 Nm
F: 6,2 Nm  
E: 3,2 Nm
Reflexive
Reflexive Looptime Rlt F: 22ms  
E: 32ms
F: 24ms  
E: 23ms
Area under the M1 curve Rauc_m1 F: 0,16 E: 0,01 F: 0,05  
E: 0,05
Threshold angle Rta F: 53 deg  
E: – 
F: 55 deg  
E: -
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Table 3 | Parameters following from the system identification technique tested on a paretic chronic 
stroke patient (pt. A) and a functionally recovered chronic stroke patient (pt. B).
Parameter Patient A Patient B
Passive
Stiffness at Restangle Pk 2,8 Nm/rad 1,0 Nm/rad
Damping at Restangle Pd 0,07 Nms/rad 0,05 Nms/rad
Active
Additional activation induced muscle stiffness at Restangle Ak_act 8,3 Nm/rad 8,3 Nm/rad
Additional activation induced muscle damping at Restangle Ad_act 0,08 Nms/rad 0,08 Nms/rad
Reflexive
Reflexive Looptime Rtd_st 30 ms 29 ms
Reflexive contributions to joint resistance Rkv_st 0,080 Nms/rad 0,092 Nms/rad
Reflex modulation due to activation Rm_act 0,06 Nms/rad 0,06 Nms/rad
Reflex modulation due to environmental changes Rm_env 0,01 Nms/rad -0,06 Nms/rad
DISCUSSION
We presented a methodology that can be used to obtain insight into the potential roles 
of passive, active and reflexive contributors to movement disorders. Using a combination 
of test conditions and available analysis methods it is possible to discriminate different 
contributors of the movement disorder. We used this methodology to design a protocol 
that can be used to assess the role of neuromechanics in stroke recovery, to be used in 
the EXPLICIT-stroke study. This specific protocol is responsive to changes in severity of 
movement disorder. Passive parameters show altered stiffness, active parameters show 
paresis and diminished control. Reflexive parameters show altered reflex gain, loop time 
and modulation. Furthermore, differently conditioned tests have shown different values 
for the same parameter, potentially resulting in an altered role in joint dynamics for that 
specific contributor.
Compared to current, manual clinical tests such as the Ashworth test, a full protocol might 
seem cumbersome. However, a combination of different conditions or tests is required 
to determine the major contributors to a movement disorder. The presented protocol, in 
combination with a haptic manipulator (the Wristalyzer), is comprehensive yet concise, safe 
and non-invasive. 
With the current setup it is not possible to discern continuous involuntary active tissue from 
passive viscoelastic properties during passive tasks. Furthermore, specifically for some of 
the active tests in the EXPLICIT-stroke protocol, a certain amount of independent control 
of agonist and antagonist muscles is required, which some patients will not be able to 
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perform. However, these tests can still give valuable results. The issued parameters reflect 
the properties of a highly non-linear system. As such, presented parameters are to be 
considered a mean over e.g. a movement trajectory. Non-linear identification techniques 
should be developed to assess instantaneous determinant characteristics during true 
functional tasks. Furthermore, there are some indications that patients particularly have 
trouble adapting from one state to the next [19], as opposed to attaining that new state at 
all. Adding time variance (e.g., in task instruction or virtual environments) during tests could 
highlight differences between stroke patients and healthy subjects.
The primary outcome measures will be validated in a larger group of chronic patients 
versus a control group of healthy subjects. Furthermore, longitudinal analysis of changes in 
neuromechanics in acute and subacute stroke patients will be conducted in the EXPLICIT-
stroke program [5], a program targeted at understanding the relation of primary neural 
repair to behavioural compensation in arm function recovery. This multicenter research 
project comprises the longitudinal assessment of parameters of functional recovery 
(clinimetrics), recovery of cortical activation (fMRI), intactness of corticospinal tract (TMS) and 
compensation strategies (kinematics). Neuromechanics describe the integration of neural 
and muscle activation, determining actual functional performance. As such, the assessment 
of neuromechanics within the EXPLICIT-stroke study is essential in understanding the 
relation between primary (neural) lesion and functional performance.
CONCLUSION
A comprehensive, yet concise assessment protocol was developed to identify tissue, active 
muscular and reflexive properties at joint level. Application of the protocol illustrates the 
necessity to apply multiple measurement and task conditions to identify patients within 
a spectrum of neuromechanical system functions and to ultimately understand the 
underlying mechanism of a movement disorder after neural lesions.
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APPENDIX I | MEASUREMENT SETUP
Based on the earlier work on wrist manipulators [22] a torque controlled haptic wrist 
manipulator has been developed, called the Wristalyzer®, (MOOG, Nieuw Vennep, the 
Netherlands) [16] in collaboration with the Delft University of Technology and the Leiden 
University Medical Center (Figure 9). The setup consists of a main drive of a vertically 
positioned servo motor (Parker SMH100 series). The arm is fixated to the Wristalyzer and the 
hand is fixated to the handle. The motor axis is aligned with the rotation axis of the wrist 
joint. Movement of the motor is therefore directly coupled to flexion/extension of the wrist. 
The handle has an ellipsoidal shape which, because of its length, prevents finger flexion 
(Figure 9). 
Wristalyzer 
Handle ROM ≈ 180°; accuracy 0.35°
Nominal motor torque is 6Nm
Magnetic break torque 20Nm
Maximal angular velocity 2000deg/s [16] 
Encoder (Hiperface absolute single turn)
Strain gauge (mounted between the axis and handle)
EMG
Muscle activation was measured using a Delsys Bagnoli-8 system with bipolar surface 
electrodes on the Flexor Carpi Radialis (FCR) and two on the Extensor Carpi Radialis (ECR).
Measurement computer
A laptop is used for data processing and visualization. Matlab® R2007a was used for 
communication with the Wristalyzer and Matlab® R2008b was used for data analysis.
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Figure 9 | Top-view of the Wristalyzer®, (MOOG, Nieuw Vennep, the Netherlands).
Abbreviations
ECR – Extensor carpi radialis;
EMG – Electromyography;
EXPLICIT-stroke – EXplaining PLastICITy after stroke; 
FCR – Flexor carpi radialis;
FRF – Frequency response function;
ROM – Range of motion;
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ABSTRACT
Background
Understanding movement disorder after stroke and providing targeted treatment for post 
stroke patients requires valid and reliable identification of biomechanical (passive) and 
neural (active and reflexive) contributors. Aim of this study was to assess test-retest reliability 
of passive, active and reflexive parameters and to determine clinical responsiveness in a 
cohort of stroke patients with upper extremity impairments and healthy volunteers.
Methods
Thirty-two community-residing chronic stroke patients with an impairment of an upper limb 
and fourteen healthy volunteers were assessed with a comprehensive neuromechanical 
assessment protocol consisting of active and passive tasks and different stretch reflex-
eliciting measuring velocities, using a haptic manipulator and surface electromyography of 
wrist flexor and extensor muscles (Netherlands Trial Registry number NTR1424).
Intraclass correlation coefficients (ICC) and Standard Error of Measurement were calculated 
to establish relative and absolute test-retest reliability of passive, active and reflexive 
parameters. Clinical responsiveness was tested with Kruskal Wallis test for differences 
between groups.
Results
ICC of passive parameters were fair to excellent (0.45 to 0.91). ICC of active parameters 
were excellent (0.88 – 0.99). ICC of reflexive parameters were fair to good (0.50 – 0.74). 
Only the reflexive loop time of the extensor muscles performed poor (ICC 0.18). Significant 
differences between chronic stroke patients and healthy volunteers were found in ten out 
of fourteen parameters.
Conclusions
Passive, active and reflexive parameters can be assessed with high reliability in post-
stroke patients. Parameters were responsive to clinical status. The next step is longitudinal 
measurement of passive, active and reflexive parameters to establish their predictive value 
for functional outcome after stroke.
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BACKGROUND
Upper extremity movement disorder is a major contributor to impaired activity and 
participation levels in post-stroke patients [1,2]. In the acute phase after stroke, paresis is the 
dominant factor of impairment [3,4]. However, in the chronic phase, the complex interaction 
between inappropriate neural activation of muscles and secondary biomechanical changes 
in contractile muscle tissue and passive viscoelastic connective tissue becomes more 
prominent [3-6]. The dynamical interactions between neural capacity and contractile and 
connective tissues during daily functioning in patients are poorly understood. 
Unraveling movement disorder after stroke into non-neural (passive) and neural (active 
and reflexive) contributors and assess their separate influence over time, is essential to 
understand functional recovery after stroke and to aim therapy at the most dominant 
contributing factor at the most appropriate moment in time [7-10]. Physical examination 
is currently the most utilized clinical tool for assessment of paresis, inappropriate muscle 
activity and secondary biomechanical changes [11].
Biomechanical and electrophysiological techniques support standardization of input signals 
and uniform registration of output signals. A comprehensive neuromechanical assessment 
should be able to discriminate between non-neural and neural contributors to movement 
disorder [7-10,12]. Non-neural contributors, i.e. passive tissue properties, should be 
measured by passive movement at low velocity to minimize background muscle activation 
[13]. Neural contributors should be measured during active tasks to study voluntary muscle 
properties and during multiple measurement velocities to study the role of stretch reflexes 
[3,4,7-10,12]. System Identification and Parameter Estimation techniques assist in separation 
of neural and non-neural contributors independently of task and condition [14].
Earlier work on measurement of joint neuromechanics [15-19] provided a comprehensive 
assessment protocol including passive, active and reflexive tests to measure non-neural and 
neural contributors to movement disorder after stroke [20]. To ensure standardized input 
signals and registration of output signals, a haptic wrist manipulator [21,22] was combined 
with surface-EMG measurements.
Clinical implementation of this newly developed protocol required validation. The aim of 
this study was to assess test-retest reliability and to determine clinical responsiveness in 
a cohort of stroke patients with upper extremity impairments compared to a cohort of 
healthy volunteers.
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METHODS
Participants
We identified patients who survived a first ischemic stroke between 1999 – 2009, and 
were between 18 – 80 years at time of stroke, at the outpatient clinics of the Department 
of Rehabilitation in LUMC and Rijnlands Rehabilitation Center. Inclusion criteria were: a 
perceived remaining impairment of arm-hand function by the participant, being able to 
travel to the research laboratory, and being able to sit on a chair and follow instructions 
for one hour. To establish the perceived impairment of arm-hand function, respondents 
were asked if they still perceived any impairment of the arm and/or hand. Possible answers 
were: no impairment, moderate impairment or severe impairment. Patients with moderate 
to severe perceived impairment were invited for measurements. Exclusion criteria were: 
limitations of arm-hand function prior to stroke, a history of other neurologic impairments 
besides stroke. Participants were measured on two occasions within a month, assuming 
that their clinical status would remain stable. A volunteer sample of healthy volunteers 
served as a reference group. The study was approved by the Medical Ethical Committee of 
the LUMC. All participants were compensated for travel expenses.
Protocol
Measurements were carried out in a laboratory setting at the LUMC. Before the test protocol 
started, the modified Ashworth Scale (mAS) was measured. Participants were extensively 
instructed and were given ample opportunity to practice. The protocol consisted of nine 
tests, with a total duration of approximately 45 minutes. 
Measurement set-up
The measurement set-up [20] consisted of a haptic manipulator (“Wristalyzer”, Moog FCS, 
the Netherlands) and a surface EMG-system (“Bagnoli”, Delsys Inc., USA). The manipulator 
delivered precise torque or position perturbations through a vertically positioned servo-
motor (Parker SMH100 series), connected to a handle (Meester techniek, the Netherlands). 
The hand of the participant was fixed to the handle, which had an ellipsoidal shape to 
prevent finger flexion (Figure 1). The arm was stabilized in an arm rest. The motor axis was 
aligned with the rotation axis of the wrist joint. Movement of the motor was therefore 
directly coupled to flexion/extension of the wrist.
Tasks, conditions and outcome parameters
An overview and more elaborate description of applied Passive, Active and Reflexive tests 
and their outcome parameters is shown in Table 1. The tests were performed in a fixed 
order, starting with Passive tests, followed by Active and Reflexive tests respectively [20]. 
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Participants were provided with visual feedback on torque, angle or EMG-level, depending 
on the test and task instruction.
Table 1 | Description of Passive, Active and Reflexive parameters. 
Adapted from Klomp et al 19.
Parameter Description
Passive    
Range of motion passive (degrees) PROM Slow passive movement through range of motion, 
maximum torque is 2Nm. Range of motion equals the 
difference between minimal and maximal angle.
Stiffness in rest (Nm rad-1) Pk Resistance to passive movement during a slow, position 
controlled, passive movement through range of motion. 
Average negative tangent of the hysteresis curve over 0.2 
rad around PRA.
Rest angle (degrees) PRA Angle at which the resultant torque during a slow, position 
controlled, passive movement through range of motion 
is zero.
Active    
Range of motion active (degrees) AROM Voluntary movement through range of motion, no 
resistance from haptic robot. Range of motion equals the 
difference between minimal and maximal angle.
Maximal voluntary contraction (Nm) AMVC Maximal torque generated by participant. Fixed position 
at PRA.
Control over joint torque (Nm) ACJT Ability of participant to achieve steadily increasing target 
torque. Fixed position at PRA.
Reflexive    
Threshold angle (degrees) Rta Angle at which the EMG exceeds 5 times the standard 
deviation of baseline during a fast, position controlled 
passive movement through total range of motion.
Reflex loop time (s) Rlt Time from perturbation onset to M1-reflex onset. 
Participant is asked to deliver 10% of maximum EMG-
activity during a position controlled movement over 0.14 
rad at 3 rad/s.




Rkv Participant is asked to resist fast multisine force 
perturbations. Velocity dependent reflex gain is computed 
using system identification methods.




Rm_env Participant is asked to resist fast multisine force 
perturbations in a damped environment. Velocity 
dependent reflex gain in a damped environment is 
computed.
Passive tests were performed at low velocity to avoid stretch reflexes, and included a task 
instruction to “do nothing”. First, a force controlled movement was applied in flexion and 
extension direction, to establish passive range of motion passive (PROM). Then a position 
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controlled movement was applied, also in both flexion and extension direction. The 
following outcome parameters were extracted: Stiffness in rest (Pk) and Rest angle (PRA) 
(Table 1).
Active tests comprised task instructions to “move/push/resist”, i.e. exert a voluntary torque or 
complete a voluntary movement. This part commenced with an active, maximal movement 
from flexion to extension and back to establish active range of motion active (AROM). Then, 
the position of the handle was fixed at the PRA and participants were asked to complete and 
repeat a maximal voluntary isometric contraction in both flexion and extension direction 
to establish active maximal voluntary contraction (AMVC). Subsequently, participants 
were asked to match a gradually inclining torque level. This was also performed in both 
flexion and extension direction and repeated once. The following outcome parameter was 
extracted: Control over joint torque (ACJT) (Table 1).
Reflexive tests were performed at velocities above the assumed stretch reflex threshold, and 
had either passive or active task instructions. A high velocity, position controlled movement 
through the PROM was applied once, in both flexion and extension direction (passive task 
instruction) to calculate Threshold angle (Rta). Short ramp and hold position perturbations 
were applied 9 times in each direction at random time intervals (active task instruction) to 
extract Reflexive loop time (Rlt). A multisine force perturbation was applied for 20 seconds 
(active task instruction) and repeated three times: once in the same environment and twice 
in a damped environment. The following outcome parameters were extracted: Reflexive 
contributions to joint resistance (Rkv) and Reflex modulation due to environmental changes 
(Rm_env) (Table 1).
Statistical analysis
Data was retrieved and processed with Matlab 2007b (Mathworks, USA) [20]. Calculations 
and statistics were performed with SPSS Statistics 20 (IBM, USA). Sample size was calculated 
on the outcome parameter with the expected largest variability: Rkv. In an earlier study, 
a standard deviation of 0.17 Nms/rad was found [17] , with a mean difference between 
patients and controls of 0.12 Nms/rad. Based upon α = 0.05 and with a target power of 
80%, a sample size of minimally 10 participants was estimated to be required to detect an 
existing difference between measurements of 0.12 Nms/rad with sufficient power.
Intraclass correlation coefficients (ICC) were calculated using the two-way mixed model for 
absolute agreement. Values above 0.75 represent excellent reliability, values between 0.4 
and 0.75 represent fair to good reliability and values below 0.4 represent poor reliability 
[23]. As ICC is a relative measure dependent on variance within a group [24], Bland Altman 
plots were used to illustrate variability and Standard Error of Measurement (SEM) values 
(Equation 1) and Smallest Detectable Difference (SDD) (Equation 2) were calculated to 
further substantiate ICC. 
Equation 1.   SEM = SD*√(1-ICC)
Equation 2.   SDD = 1.96 * √2*SEM
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Figure 1 | Illustration of Wristalyzer handle and arm-rest. 
For a better view of the hand position, the hand straps are not represented in this illustration.
Normality of distribution was assessed by visual inspection of histograms and equality of 
variance was tested with Levene’s test. Median, minimum and maximum were calculated 
per parameter. Levene’s test showed wider variances in the group of chronic stroke patients 
compared to healthy volunteers, therefore chronic stroke patients were split in two groups 
according to mAS (mAS = 0 and mAS ≥ 1), a clinimetric observation. This allowed for a 
more specific description of phenotypes and more equally dispersed values within each 
group, which was illustrated with box plots. An exploratory comparison was made between 
parameters of the group of healthy volunteers, the group of chronic patients with mAS = 0 
and the group of chronic patients with mAS ≥ 1, using the non-parametric Kruskal-Wallis 
test. The Kruskal-Wallis test was performed on the average outcome of the two visits per 
parameter, after testing for systematical differences between the two visits. This comparison 
was further substantiated by pairwise testing between each of the groups with the non-
parametric Wilcoxon Rank Sum test. 
RESULTS
Descriptive data
We identified and invited 102 post stroke patients. Response rate was 64% (n = 65). Of 
the responders, 17 patients declined to participate and 16 patients had either no current 
impairment of arm-hand function or had severely impaired mobility preventing them from 
travelling to the clinic. Therefore, 32 patients were included in the study. Fourteen healthy 
volunteers served as a reference group. All healthy volunteers completed the two visits and 
28 out of 32 patients completed all visits (87.5%). Reasons for dropping out were: unable 
to schedule the second visit (n = 2), visit was too tiresome (n = 1), patient was treated with 
botulinum toxin in period between first and scheduled second visit (n = 1). In chronic stroke 
patients, the affected hand was dominant in 14 patients (right hand n = 13, left hand n = 1) 
and non-dominant in 18 patients (right hand n = 2, left hand n = 16). Average age at stroke 
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was 55.2 years. Average time after stroke was 40 months. Descriptive data are presented in 
Table 2.
Reliability
Test-retest reliability for Passive parameters was excellent for PROM and Pk (ICC 0.81 and 0.91 
respectively) and fair to good for PRA (ICC 0.45). For Active parameters, test-retest reliability 
was excellent (ICC 0.88-0.99). For Reflexive parameters, the ICC’s of Rta (flexor and extensor), 
Rlt (flexor), Rkv and Rm_env were fair to good (ICC 0.50 – 0.74). ICC for Rlt (extensor) was poor 
(ICC 0.18). ICC’s are summarized in Table 3. Bland Altman plots are shown in Figure 2, 
depicting the mean of the two measurements (x-axis) compared to the difference between 
two measurements (y-axis). The values are scattered around the mean difference (solid 
line), illustrating the absence of a systematic difference or learning effect between the two 
measurements. In parameters with a lower ICC, the 95% confidence interval of the difference 
between the measurements is wider, illustrating a larger measurement error. SEM values 
(Table 3) provide an indication of the dispersion of the measurement errors and SDD are 
given for future reference (Table 3).
Table 2 | Descriptive data of the study population. 
Means and standard deviation or percentages for healthy volunteers and chronic stroke patients.








Age (years) (SD) 49.4 (15.1) 60.4 (13.1) 54.5 (12.7)
Men (n) (%) 9 (64%) 10 (48%) 3 (27%)
Right side dominant (n) (%) 13 (93%) 21 (100%) 8 (73%)
Measured side dominant (n) (%) 14 (100%) 10 (48%) 4 (36%)
Time between measurements (days) (SD) 27 (21) 18 (7) 29 (17)
Time after stroke (months) (SD) – 30 (27.6) 53 (34.3)
Age at moment of stroke (years) (SD) – 58 (13.1) 50 (14.5)
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Table 3 | Median, minimum and maximum, Intraclass correlation coefficients (ICC) , Standard Errors 
of Measurement (SEM) and Smallest Detectable Difference (SDD) for Passive, Active and Reflexive 
parameters for all participants. 
PROM: Range of motion passive, Pk: Stiffness in rest, PRA: Rest angle. AROM: Range of motion active, AMVC: Maximal voluntary contraction, 
ACJT: Control over joint torque. Rta: Threshold angle, Rlt: Reflexive loop time, Rkv: Reflexive contributions to joint resistance, Rm_env: 
Reflex modulation due to environmental changes. *: average of SEM and SDD for Rta flexor and Rlt extensor, valid around median 
of both parameters. Because of heteroscedasticity, SDD and SEM might be smaller towards minimum of parameter and might be 
larger towards maximum of parameter.
Parameter   All participants ICC SEM SDD
    median [min;max]    
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Responsiveness to clinical status
An overview of outcomes per group is summarized in Table 4. Dropout rates were similar in 
both chronic patient groups (mAS = 0: n = 2 and mAS ≥ 1: n = 2). Differences between healthy 
volunteers, chronic stroke patients with mAS = 0 and chronic stroke patients with mAS ≥ 
1 are illustrated by box plots in Figure 3. Corresponding quartiles are given in Appendix 
A. In 10 out of 14 parameters, these differences were statistically significant, based on the 
exploratory Kruskal Wallis test (Table 4). When tested pairwise with the Wilcoxon Rank Sum 
test (Appendix B), there were significant differences between healthy volunteers and the 
mAS=0 group in the Passive parameters Pk and PRA; the Active parameters AROM, AMVC (flexor 
and extensor) and ACJT (flexor and extensor); and the Reflexive parameters Rlt (extensor) and 
Rkv. Differences between healthy volunteers and the mAS≥1 group showed significance in 
PROM, all Active parameters, Rta (extensor) and Rkv . When comparing the mAS=0 group and 
mAS ≥1 group, there were significant differences in PROM, Pk and all Active parameters, but 
no significant differences in Reflexive parameters.
DISCUSSION 
Using a dedicated, comprehensive neuromechanical assessment protocol, Passive and 
Active parameters could be assessed with excellent reliability in a cohort of stroke patients 
with upper extremity impairments and healthy volunteers. Repetitive assessment of the 
Passive parameter PRA and Reflexive parameters had fair to good reliability, except for 
poor reliability of Rlt (extensor). Parameters were responsive to clinical status, i.e. results 
demonstrated differences between healthy volunteers and chronic stroke patients.
The use of a haptic robot in combination with surface EMG provides standardized application 
of input signals and registration of output signals. Participants could comfortably tolerate 
the position in the measurement set-up and the length of the protocol. Previous publication 
of measurement set-up, protocol and data processing [20] and current assessment of test-
retest reliability and clinical responsiveness add to the clinical validity of our method, which 
is advantageous for prospective implementation of this method in clinical practice. 
Relative reliability expressed by ICC’s is both determined by heterogeneity of the study 
group and the variance on the repeated measurements. In homogenous study groups, 
relative reliability may drop. For future assessment of longitudinal changes, variability of 
neuromechanical outcome parameters is unknown and may be dependent on the time of 
measurement, i.e. low heterogeneity early after stroke when the paresis component prevails 
and large heterogeneity when secondary biomechanical changes become manifest. We 
therefore adopted the present cohort-approach to minimize a-priori assumptions on 
heterogeneity within groups. 
66 | Chapter 4
Table 4 | Median, minimum and maximum for healthy volunteers, chronic patients with modified 
Ashworth score (mAS) = 0 and chronic patients with mAS ≥ 1 , and p-value of the Kruskal Wallis test for 
differences between groups for Passive, Active and Reflexive parameters. 
PROM: Range of motion passive, Pk: Stiffness in rest, PRA: Rest angle. AROM: Range of motion active, AMVC: Maximal voluntary contraction, 
ACJT: Control over joint torque. Rta: Threshold angle, Rlt: Reflexive loop time, Rkv: Reflexive contributions to joint resistance, Rm_env: 
Reflex modulation due to environmental changes. #: significant difference between groups.
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Measures of absolute reliability can be used to calculate the SDD, i.e. the difference between 
measurements that can be attributed to real system changes. For example in AROM the SDD 
is 14 degrees, meaning that a change of 14 degrees or over can be attributed to a genuine 
change in patient characteristics in 95% of cases. SEM values for PROM, Pk, AROM, AMVC and ACJT 
were low. These are sensitive parameters for real system changes, indicative for both passive 
as well as active contributors to observed movement disorders. We therefore recommend 
these parameters for future assessment of longitudinal neuromechanical changes.
In all Passive, Active and Reflexive parameters except Pk, PRA and Rlt (extensor), differences 
between healthy volunteers and patients in the mAS ≥ 1 group were more pronounced 
than differences between healthy volunteers and patients in the mAS = 0 group. However, 
parameters did not always increase or decrease proportionally between groups, which 
illustrates the complex and non-linear nature of movement disorder after stroke. In the 
mAS = 0 group, the paresis component probably plays an important role, while the ability 
for voluntary motor control is more preserved than in the mAS ≥ 1 group (as can be seen 
from AMVC and ACJT), leading to a lower stiffness (Pk) in passive structures (i.e. muscle, tendon, 
ligament). Test-retest results showed good reproducibility, however, the remarkable inter-
individual variation in passive and active parameters in the group of chronic patients may 
represent the different phenotypes in post stroke motor control.
Strengths and limitations
The perturbations in our protocol may not have been enough to trigger the stretch reflex 
threshold of the extensor muscles, which are more difficult to trigger [25]. This could have 
contributed to a lower repeatability in Reflexive parameters Rlt (extensor) and Rta (extensor), 
and a larger SDD than expected for Rkv. Other contributing factors may be found in a low 
signal to noise ratio, i.e. absence of inappropriate muscle activity in healthy volunteers and 
in chronic stroke patients with mAS = 0. Furthermore, variability in Reflexive parameters is 
known to be present in both healthy volunteers and chronic patients [26-29], even in optimal 
circumstances. Stretch reflex behavior is more variable than passive tissue properties and 
voluntary muscle properties [29-31]. Apart from day-to-day variability in stretch reflex 
behavior [27,29], there is also variability due to level of arousal, audiovisual stimuli and 
other environmental factors [32,33], as well as conscious down- or up-regulation [34]. These 
methodological considerations, combined with the unequal variances in subgroups, might 
account for heteroscedasticity, especially in Rta flexor and Rlt extensor. SEM and SDD for 
these values should be interpreted bearing in mind that SDD and SEM might be smaller 
towards the minimum of the parameter and might be larger towards the maximum of both 
parameters.
Although sufficient for the aim of this study, group sizes were small. Current subdivision 
of clinical phenotypes according to mAS is a fairly rough approximation of clinical status 
and more participants may be needed for a more elaborate post-hoc analysis. The adopted 
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cohort approach is an estimation of group heterogeneity. The neuromechanical assessment 
protocol aimed to identify passive, active and reflexive contributors to movement disorder 
by differences in task and measurement conditions. For example: the protocol was designed 
to minimize the effects of active and reflexive (neural) contributors during passive (non-
neural) tasks and vice versa. However, this might not yet give a completely true reflection 
of neuromechanical behavior, as system behavior under active task conditions involves 
a combination of both neural and non-neural contributors. The same goes for passive 
conditions, where neural components may be present through increased baseline activation 
[13]. Further development of System Identification and Parameter Estimation techniques 
might help to zoom in even closer on the specific contributors to neuromechanical behavior.
Implications for future work
One of the objectives of the EXPLICIT-stroke project [35] will be to combine the 
neuromechanical approach with extensive clinimetric data. Simultaneously, in this project, 
longitudinal measurements will be used to provide information on the changes in paresis, 
the development of secondary biomechanical changes and the increase of inappropriate 
muscle activity over time. This should provide the necessary data to enhance description 
of clinical phenotypes by clustering of neuromechanical parameters, and, moreover, to 
predict functional outcome.
CONCLUSIONS
Passive, Active and Reflexive parameters, representing passive tissue properties, voluntary 
muscle function and stretch reflex behavior respectively, can be measured in a reliable way. 
The comprehensive neuromechanical assessment protocol is responsive to clinical status 
and fulfills the requirements to separately assess non-neural and neural contributors to 
movement disorder around the wrist after stroke, using biomechanical, electromyographical 
and system identification techniques [7-10,12]. Therefore, this protocol gives momentum 
to future work on connecting pathophysiology to functional outcome, which will enable 
clinicians to substantiate their treatment.
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APPENDICES
Appendix A | Quartiles of Passive, Active and Reflexive parameters for healthy volunteers, chronic 
patients with modified Ashworth score (mAS) = 0 and chronic patients with mAS ≥ 1. 
PROM: Range of motion passive, Pk: Stiffness in rest, PRA: Rest angle. AROM: Range of motion active, AMVC: Maximal voluntary contraction, 
ACJT: Control over joint torque. Rta: Threshold angle, Rlt: Reflexive loop time, Rkv: Reflexive contributions to joint resistance, Rm_env: 
Reflex modulation due to environmental changes.







PROM  (degrees) healthy volunteer 133 138 146
chronic patient mAS = 0 126 132 141
chronic patient mAS> = 1 75 100 112
Pk (Nm rad
-1) healthy volunteer 1.43 1.72 2.01
chronic patient mAS = 0 0.76 0.85 1.06
chronic patient mAS> = 1 1.15 1.44 2.75
PRA (degrees) healthy volunteer -58 -52 -43
chronic patient mAS = 0 -45 -33 -19
chronic patient mAS> = 1 -66 -52 -27
Active  
AROM  (degrees) healthy volunteer 141 146 149
chronic patient mAS = 0 124 128 136




healthy volunteer 19.5 25.2 27.2
chronic patient mAS = 0 11.8 18.4 25.0
chronic patient mAS> = 1 1.4 2.2 7.8
AMVC extensor (Nm) healthy volunteer 10.4 14.9 20.6
chronic patient mAS = 0 7.0 10.5 13.9
chronic patient mAS> = 1 0.2 1.1 2.1
ACJT flexor (Nm) healthy volunteer 15.6 17.3 17.9
chronic patient mAS = 0 6.6 12.4 18.3
chronic patient mAS> = 1 0.0 2.2 6.1
ACJT extensor (Nm) healthy volunteer 9.9 12.7 17.1
chronic patient mAS = 0 4.9 7.8 10.2
chronic patient mAS> = 1 0.0 0.0 2.2
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Rta flexor (degrees) healthy volunteer -77 -71 -41
chronic patient mAS = 0 -76 -72 -13
chronic patient mAS> = 1 -68 -54 -36
Rta extensor (degrees) healthy volunteer 3 35 47
chronic patient mAS = 0 -16 19 36
chronic patient mAS> = 1 -69 -64
Rlt flexor (s) healthy volunteer 0.025 0.028 0.031
chronic patient mAS = 0 0.024 0.030 0.033
chronic patient mAS> = 1 0.024 0.027 0.030
Rlt extensor (s) healthy volunteer 0.029 0.037 0.035
chronic patient mAS = 0 0.032 0.036 0.040
chronic patient mAS> = 1 0.031 0.036 0.039
Rkv (Nms rad
-1) healthy volunteer -0.040 -0.015 0.010
chronic patient mAS = 0 -0.021 0.025 0,084
chronic patient mAS> = 1 0.016 0.053 0.105
Rm_env (Nms rad
-1) healthy volunteer -0.053 -0.006 0.033
chronic patient mAS = 0 -0.032 0.044 0.122
chronic patient mAS> = 1 -0.001 0.032 0.041
77Reliability and responsiveness | 
4
Appendix B | Pairwise comparison with Wilcoxon Rank Sum test between healthy volunteers, chronic 
patients with mAS = 0 and chronic patients with mAS ≥ 1.
#: significant difference between pair. The Kruskal Wallis test results are repeated from Table 4 for reference. PROM: Range of motion 
passive, Pk: Stiffness in rest, PRA: Rest angle. AROM: Range of motion active, AMVC: Maximal voluntary contraction, ACJT: Control over 
joint torque. Rta: Threshold angle, Rlt: Reflexive loop time, Rkv: Reflexive contributions to joint resistance, Rm_env: Reflex modulation 
due to environmental changes.








Chronic patients Chronic patients Chronic patients
mAS = 0 mAS≥1 mAS≥1
Passive
PROM (degrees) p < 0.001
# p = 0,059 p < 0.001# p < 0.001#
Pk (Nm rad
-1) p < 0.001# p < 0.001# p = 0.682 p = 0.001#
PRA (degrees) p=0.013
# p = 0.004# p = 0.725 p = 0.063
Active
AROM (degrees) p < 0.001
# p = 0.001# p < 0.001# p < 0.001#
AMVC (Nm) flexor p < 0.001
# p = 0.026# p < 0.001# p < 0.001#
extensor p < 0.001# p = 0.031# p < 0.001# p < 0.001#
ACJT (Nm) flexor p < 0.001# p = 0.086 p < 0.001
# p < 0.001#
extensor p < 0.001# p = 0.002# p < 0.001# p < 0.001#
Reflexive
Rta (degrees) flexor p=0.221 p = 0.596 p = 0.094 p = 0.202
extensor p=0.031# p = 0.096 p = 0.032# p = 0.057
Rlt (s) flexor p=0.537 p = 0.711 p = 0.413 p = 0.288
extensor p=0.097 p = 0.041# p = 0.102 p = 0.856
Rkv (Nms rad
-1) p=0.017# p = 0.043# p = 0.006# p = 0.268
Rm_env (Nms rad
-1) p=0.192 p = 0.138 p = 0.076 p = 0.845
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ABSTRACT 
Purpose
Loss of selective muscle activation after stroke contributes to impaired arm function, is 
difficult to quantify and is not systematically assessed yet. The aim of this study was to 
describe and validate a technique for quantification of selective muscle activation of wrist 
flexor and extensor muscles in a cohort of post-stroke patients. Patterns of selective muscle 
activation were compared to healthy volunteers and test-retest reliability was assessed. 
Materials & Methods
Activation Ratios describe selective activation of a muscle during its expected 
optimal activation as agonist and antagonist. Activation Ratios were calculated from 
electromyography signals during an isometric maximal torque task in 31 post-stroke 
patients and 14 healthy volunteers. Participants with insufficient voluntary muscle activation 
(maximal electromyography signal < 3SD higher than baseline) were excluded.
Results 
Activation Ratios at the wrist were reliably quantified (Intraclass correlation coefficients 
0.77 – 0.78). Activation Ratios were significantly lower in post-stroke patients compared to 
healthy participants (p < 0.05). 
Conclusion
Activation Ratios allow for muscle specific quantification of selective muscle activation 
at the wrist in post-stroke patients. Loss of selective muscle activation may be a relevant 
determinant in assigning and evaluating therapy to improve functional outcome.
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INTRODUCTION
In post-stroke patients, impaired arm and hand function is determined by a complex 
interaction of primary neurological deficits and secondary changes in connective and 
contractile tissue [1-3]. Amidst these changes, loss of selective muscle activation plays a role 
[4-7]. The ability to voluntarily contract a muscle and to have selective control of antagonistic 
muscles predominantly defines the torque output a patient can generate during a task. 
Loss of selective muscle activation may result in energetically inefficient co-contraction and 
impaired dexterity in the affected limb [8-11]. Moreover, loss of selective muscle activation 
[12] may result in a lower torque output at joint level than expected by the level of paresis 
alone [13]. We expect clinical phenotypes to diverge from 1) patients with flaccid paresis, i.e. 
no selective muscle activation, to 2) patients with some loss of selective muscle activation, 
and 3) patients with normal selective muscle activation combined with either low or normal 
torque output. Addressing the role of selective muscle activation to loss of function is 
important in clinical decision making, e.g. to optimize patient selection and timing of costly 
or labor intensive therapies such as mCIMT or botulinum toxin.
Selective muscle activation is not yet assessed routinely in post-stroke patients. 
Current measures may have methodological drawbacks. For example, comparison of 
electromyography (EMG) signals of agonistic and antagonistic muscles is a frequently 
applied technique [14-18]. Yet the comparison of agonist and antagonist EMG-signals is for 
instance troubled by differences in volume of the muscles in an agonist-antagonist muscle 
pair [19,20] and complicated in case of spasticity [9], which makes quantification of selective 
muscle activation with this technique challenging. Furthermore, quantification of selective 
muscle activation by comparison of EMG-signals of the same muscle in the ipsilateral and 
contralateral sides [13,21] may be hampered, as muscle properties of the unaffected side 
should not be regarded as normal in post-stroke patients [22-26]. Moreover, proper address 
of selective muscle activation is of importance as morphological changes interfering with 
contractile behavior are already reported in the early phase after stroke [27].
In this study we describe selective muscle activation by comparing EMG-signals of wrist 
muscles during two isometric but antagonistic task conditions, using the normalized ratio 
of the EMG-signals per muscle group, also called Activation Ratio (AR) [28]. This method 
is methodologically advantageous because it describes the activation of both flexor and 
extensor muscles in relation to their expected agonistic and antagonistic function. AR 
may be applied to antagonist muscle pairs provided the axis of movement is controlled 
(limitation in degrees of freedom). Selective muscle activation around the wrist joint had 
our special interest because of its role in lasting impairment in arm-hand function after 
stroke, e.g. in case of flexion deformity. Muscle specific AR is assumed to assist in a better 
definition of clinical phenotypes in post-stroke patients. However, this method has not been 
evaluated in post-stroke patients yet. Our aim was to describe and validate this technique 
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for quantification of selective muscle activation of wrist flexor and extensor muscles in a 
cohort of post-stroke patients. Patterns of selective muscle activation were compared to 
healthy volunteers and test-retest reliability was assessed.
METHODS
Participants 
The study cohort consisted of 31 stroke survivors and 14 healthy volunteers. Post-stroke 
patients were recruited from an outpatient rehabilitation department. Inclusion criteria 
were: first ischemic stroke between 1999 – 2009, age 18 – 80 years, a perceived persistent 
impairment of arm-hand function by the participant, being able to travel to the research 
laboratory, and being able to sit on a chair and follow instructions for one hour. Exclusion 
criteria were: previous orthopedic limitations of arm-hand function, a history of other 
neurologic impairments besides stroke. Participants were measured between November 
2008 and January 2010 on two occasions within a month, under the assumption that clinical 
status would remain stable. Stroke onset was more than 6 months prior to assessment. 
Ethical approval for the study was received from the medical ethical committee at the 
Leiden University Medical Center and written informed consent was obtained from each 
participant prior to testing.
Protocol
Participants were instructed to perform a voluntary isometric maximal flexion or extension 
torque, starting from a relaxed condition. The voluntary maximal isometric torque (MIT) 
had to be attained within a 15 second timeframe, followed by a minimum of 60 seconds 
rest. This procedure was performed twice for both flexion and extension. The position of 
the wrist during the test was a neutral angle where the average measured torque during 
a slow passive movement through the range of motion was 0 Nm (Rest Angle) [29]. For 
motivational purposes, visual feedback was provided on a computer screen. This feedback 
consisted of a vertical bar which showed both instantaneous and maximal attained torque.
Measurement set-up
Tests were performed on a haptic wrist manipulator (Wristalyzer®, Moog FCS, Nieuw Vennep, 
the Netherlands) [30], on which torque and wrist joint angle were recorded. Participants 
were comfortably seated on a chair in front of a video screen. The forearm of the participant 
was positioned horizontally with the elbow in 90° flexion. The hand was strapped to an 
ellipsoidal shaped handle (Figure 1) to prevent finger flexion and hand closure. The skin at 
the electrode positions was cleansed with alcohol and lightly abraded with skin preparation 
gel (SkinPure, Nihon Kohden, Japan). EMG activity of the m. flexor carpi radialis (FCR) and 
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m. extensor carpi radialis longus and brevis (together abbreviated as ECR) was recorded 
by bipolar parallel bar surface electrodes (Bagnoli® DE-2.1, Ag, single differential, inter 
electrode distance 10 mm; Bagnoli-8 amplifier, Delsys Inc., Boston, USA). FCR and ECR 
were chosen to reflect overall muscle activity of wrist flexor and extensors. Both muscles 
are the less pennate muscles of the lower arm, have good accessibility with surface EMG 
and are therefore likely to suffer less from measurement artefacts. Two bipolar electrodes 
were placed on each muscle group to ensure that a signal was available and to compensate 
for spatial alterations in the affected (atrophic) muscle after stroke [31]. Position, force and 
EMG were sampled at 2048Hz using a 16 bit analog-to-digital card (USB 6221, National 
Instruments, Austin, USA) [29]. 
Figure 1 | Photograph of Wristalyzer handle and arm-rest.
For a better view of the hand position, the hand straps are not shown.
Data processing
Data were processed with Matlab® (Mathworks, Natick, USA). Selective activation of 
FCR and ECR were computed by means of Activation Ratio (AR). This is an EMG-based 
method [28], which requires voluntary muscle activation. In patients with flaccid paresis, 
voluntary muscle activation is insufficient to distinguish between resting state and active 
conditions, and therefore insufficient to determine selective muscle activation. In this study, 
insufficient voluntary muscle activation was defined as EMG activity during the isometric 
maximal torque task of less than three times standard deviation above baseline EMG. When 
insufficient EMG activity was established for a trial, the trial was excluded from analysis. 
AR was calculated per bipolar electrode according to equation 1 [28], where AIP is the in-
phase muscle activation, i.e. activity during the agonistic task; and AOP is the out-of-phase 
muscle activation, i.e. activity during the antagonistic task of the muscle. An AR close to 
one indicates optimal in-phase (selective) muscle activation. If the AR equals zero, muscle 
activation is equal during flexion and extension. A negative AR indicates out-of-phase 
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muscle activation, i.e. the muscle is more active during its antagonistic task than during its 
agonistic task.
Equation 1 =  
( −  )
( + )
       [−1 ≤  ≤ 1]
Raw EMG signals (online band pass filter 20-450 Hz) were rectified and smoothened by a 
2Hz 3rd order Butterworth low pass filter [32]. Torque data were also smoothened with a 
3rd order Butterworth low pass filter of 2 Hz. Smoothened torque data and corresponding 
EMG signals were sorted along torque magnitude with intervals of 0.01 Nm. Then AR 
were computed for each torque level using both flexor and extensor task data within the 
available torque range (containing matching torques from both flexion and extension task) 
per bipolar electrode. The average AR was then computed per bipolar electrode, resulting 
in two AR for FCR and two AR for ECR per trial.
Statistical methods
SPSS 20 (IBM, New York, USA) was used for statistical analysis. For each participant, the 
average ARflex for FCR and average ARext for ECR per visit was computed from the mean AR 
per bipolar electrode per trial (EMG was recorded by two bipolar electrodes per muscle 
group and participants had two trials per visit), after checking for systematic differences 
between the electrodes and trials using Wilcoxon rank sum test and scatter plots.
Test-retest reliability of AR was established by Intraclass correlation coefficient (ICC) between 
the two visits. ICC were calculated using the two-way mixed model for absolute agreement. 
Values above 0.75 were assumed to represent excellent reliability, values between 0.4 and 
0.75 to represent fair to good reliability and values below 0.4 to represent poor reliability 
[33]. As ICC is a relative measure dependent on variance between measurements compared 
to total variance [34], Bland Altman plots were used to illustrate variability. Standard Error 
of Measurement (SEM) values were calculated to further substantiate ICC according to 
equation 2.
Equation 2 SEM = SD*√(1-ICC)
At parameter level, normality of distribution was inspected with histograms and equality 
of variances between healthy volunteers and post-stroke patients was tested with Levene’s 
test. Age was normally distributed, equal variances were assumed (Levene’s test p = 0.78). 
The independent samples t-test was used to compare age between healthy volunteers and 
post-stroke patients. AR were not normally distributed within groups and variance was not 
equal between groups (Levene’s test for ARflex p = 0.018, and for ARext p < 0.001), hence 
median and range were used and the non-parametric Independent Samples Median Test 
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was used for comparison between post-stroke patients and healthy volunteers. The relation 
between ARflex and ARext was tested with Spearman’s rho correlation coefficient. Ratio of 
men to women within the two groups (post-stroke patients and healthy volunteers) was 
tested with the chi-square test. 
RESULTS 
Participants 
All healthy volunteers completed all visits (100%) and 28 out of 31 patients completed all 
visits (90.3%). Reasons for dropping out were: unable to schedule the second visit (n = 2), 
patient was treated with botulinum toxin in period between first and scheduled second visit 
(n = 1). Demographics of the study population are summarized in table 1. Mean age in post-
stroke patients was 59 years (SD 13 year) and 50 years (SD 15 year) in healthy participants 
(p = 0.04 when tested for difference in age between group; 95% confidence interval for 
the difference: -18 years to -0.2 years). However, further analysis showed that age did not 
have a significant correlation with either ARflex (Pearson correlation -0.079 with p = 0.62) or 
ARext (Pearson correlation -0.139 with p = 0.38), and in multivariate analysis, age was not a 
contributing factor. Therefore age was not corrected for in further analysis. The ratio of men 
to women was not statistically different in both categories (p = 0.14). Average time post-
stroke was 3 years (SD 2.5 year). More information on limb dominance in the post-stroke 
patient group can be found in Supplementary Figure S1.
Table 1 | Demographics of the study population. 





Age (years) (SD) 49.4 (15.1) 58.5 (13.1)
Men (n) 9 (64%) 13 (42%)
Right side dominant (n) 13 (93%) 29 (94%)
Measured side dominant (n) 14 (100%) 14 (45%)
Rest Angle (degrees) (range) -52 [-64; 1] -35 [-72; -5]
Time between measurements (days) (SD) 27 (21) 22 (12)
Time after stroke (years) (SD) n.a. 3.1 (2.6)
Age at moment of stroke (years) (SD) n.a. 55.2 (13.8)
modified Ashworth Score = 0 (n) n.a. 21
modified Ashworth Score ≥ 1 (n) n.a. 10
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Voluntary muscle activation 
Three out of 172 trials were excluded because of recording errors. Insufficient voluntary 
muscle activation was observed in both FCR and ECR in three post-stroke patients, 
indicating flaccid paresis. The trials of these three patients were excluded from analysis. In 
two additional post-stroke patients, there was insufficient voluntary muscle activation in 
the ECR only. Therefore, all trials regarding the extensor muscles of these two patients were 
excluded from analysis.
Quantification of selective muscle activation 
A typical recording of a healthy participant is illustrated in Figure 2. Voluntary maximal 
isometric torque (MIT) were 28.3 Nm (flexion) and 18.4 Nm (extension). EMG activity of 
the FCR during extension was low and EMG activity of the ECR during flexion was low, 
as expected. Resulting AR in this participant were therefore close to one (ARflex = 0.82, 
ARext = 0.81), indicating a high selectivity of FCR and ECR muscle activation. 
Figure 2 | Wrist torque and EMG activity in a healthy volunteer with selective muscle activation.
Right arm measured. EMG FCR: EMG signal of m. flexor carpi radialis. EMG ECR: EMG signal of m. extensor carpi radialis longus 
and brevis.
Upper panel: red line represents flexion wrist torque. Blue line represents extension wrist torque.
Middle and Lower panel: red lines represent EMG activity during flexion. Blue lines represent EMG activity during extension. 
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Figure 3 | Wrist torque and EMG activity in a post-stroke patient with loss of selective muscle activation.
Left arm measured. EMG FCR: EMG signal of m. flexor carpi radialis. EMG ECR: EMG signal of m. extensor carpi radialis longus and 
brevis.
Upper panel: Red line represents flexion wrist torque. Blue line represents extension wrist torque.
Middle and lower panel: Red lines represent EMG activity during flexion. Blue lines represent EMG activity during extension.





























An example of a post-stroke patient with loss of selective function of the ECR is shown 
in Figure 3. Voluntary MIT were 7.8 Nm (flexion) and 5.4 Nm (extension). There was an 
increased EMG activity of the ECR during flexion. This EMG activity was almost equal to the 
EMG activity of the ECR during extension. Therefore the ARext in this participant was close to 
zero (ARext = 0.01). The FCR showed more selective activation (ARflex = 0.55). 
Activation Ratios in post-stroke patients and healthy volunteers 
Median ARflex was 0.62 and median ARext was 0.71 overall in all participants. Median and range 
of AR in post-stroke patients and healthy participants, as well as voluntary MIT per group 
are summarized in table 2. Median ARflex and ARext in post-stroke patients were significantly 
lower than in healthy participants (p = 0.022 and p = 0.003 respectively), this is graphically 
represented in Figure 4. ARflex and ARext were significantly correlated in post-stroke patients 
(Spearman’s rho 0.486, p = 0.012), but not in healthy participants (Spearman’s rho 0.262, 
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p = 0.366), which can be inferred from Figure 5. Test-retest reliability of ARflex and ARext was 
excellent with ICC of 0.77 and 0.78 respectively. Bland Altman plots are shown in figure 6, 
depicting the mean of the two measurements (x-axis) compared to the difference between 
two measurements (y-axis). The values are scattered around the mean difference (solid line), 
which is close to zero, illustrating the absence of a systematic difference or learning effect 
between the two measurements. The 95% confidence interval of the difference between 
the measurements (dotted lines) illustrates measurement error. SEM values provide an 
indication of the dispersion of the measurement errors. SEM were 0.11 for ARflex and 0.10 
for ARext. More information on the influence of variance on ICC and SEM can be found in 
Supplementary Figure S2. 
Figure 4 | Box plot for Activation Ratios of m. flexor carpi radialis (ARflex) and m. extensor carpi radialis 
communis (ARext) in post-stroke patients and healthy volunteers.
Differences between post-stroke patients and healthy volunteers are significant as tested with Independent Samples Median Test. 
P-values: p(ARflex) = 0.022, p(ARext) = 0.003.
Clinical Phenotypes 
As introduced, clinical phenotypes were expected to diverge from 1) patients with flaccid 
paresis i.e. no selective muscle activation, to 2) patients with some loss of selective muscle 
activation combined with low torque output, and 3) patients with normal selective muscle 
activation combined with either low or normal torque output. To substantiate these 
phenotypes, combinations of AR and MIT can be used. In the first phenotype, voluntary 
muscle activation is insufficient to distinguish between resting state and active conditions, 
so AR cannot be quantified. In the second phenotype, combinations of low AR with both 
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high and low MIT are found. In the third phenotype, a high AR in combination with either a 
high MIT or a low MIT is expected. Patients of phenotype 2 and 3 are graphically represented 
in Figure 7, with the dotted line representing the lowest value in healthy volunteers (ARflex 
0.15 and ARext 0.56; MITflex 16.4 Nm and MIText 4.6 Nm). High AR (representing high selective 
muscle activation) occurred within patients with both high and low MIT (right upper and 
lower quadrant in all panels), while low AR (representing low selective muscle activation) 
predominantly coincided with low MIT (left lower quadrant in all panels). The exception is 
low ARext, which coincided with both high and low MIText (left upper and lower quadrant in 
lower right panel). 
Figure 5 | Scatter plot illustrating the correlation of Activation Ratio for m. flexor carpi radialis (ARflex) 
and m. extensor carpi radialis communis (ARext).
Table 2 | Median and range of Activation Ratio and voluntary Maximal Isometric Torque in post-stroke 
patients and healthy volunteers. 
ARflex = Activation Ratio for m. flexor carpi radialis; ARext = Activation Ratio for m. extensor carpi radialis communis; MITflex = 





ARflex 0.54 [-0.02; 0.89] 0.73 [0.15; 0.90]
ARext 0.63 [-0.07; 0.79] 0.80 [0.56; 0.88]
MITflex 14.7 [0.9; 27.6] 25.2 [16.4; 28.7]
MIText 8.8 [1.1; 18.9] 14.9 [4.6; 25.4]
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Figure 6 | Bland Altman plots for Activation Ratio for m. flexor carpi radialis (ARflex) and m. extensor 
carpi radialis communis (ARext).
Solid line: mean of the difference between first and second visits. Dotted line: upper and lower limit of 95% confidence interval for 
difference between first and second visit.
DISCUSSION 
Although essential, establishing selective muscle activation does not reflect the full 
potential for treatment of a patient yet. Inappropriate muscle activation, i.e. exaggerated 
stretch reflexes, and secondary biomechanical properties, such as increased stiffness should 
also be taken into account [29,35-39]. For example, loss of selective muscle activation might 
coincide with spasticity, for which botulinum toxin could be beneficial [40-42], while loss of 
selective muscle activation combined with structural shortening of a muscle unresponsive 
to physical therapy might benefit more from surgery [43,44]. In order to tailor treatment to 
patient characteristics, each clinical phenotype requires a different approach.
Strengths and limitations 
The isotonic torque task preferred in earlier work [28] was modified to an isometric task 
during a maximal voluntary contraction. Voluntary maximal isometric torque is a widely 
used and easily applied clinimetric parameter that was already part of our test procedure. 
The necessary sorting technique to align EMG-signals along torque magnitude (that is not 
necessary in isotonic tasks) proved to be feasible. The current short task in a single torque 
direction also had the advantage of avoiding fatigue and signal modifications due to 
steering. The present measurement set-up allowed for standardization, however, further 
analysis of the dependence on orientation of the upper limb is required when test results 
are to be translated to functional task performance (i.e. reaching, grabbing). Visual feedback 
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might have supported any participants with diminished sensory functions, e.g. of the hand 
(visual feedback to compensate for lack of sensory feedback) or hemi-inattention or neglect 
(vertical bar), however, this was not tested. ICC might be different in a more homogenous 
population selected on stroke location or level of motor impairment. These data were not 
available in our population.
Figure 7 | Scatter plot of Activation Ratio versus Maximal Isometric Torque in post-stroke patients.
Dotted line: lowest values of AR and MIT in healthy volunteers (see minimum for healthy volunteers in Table 2). Patients with 
insufficient muscle activation are not represented in this figure. This figure illustrates the wide range of torque outputs for a given 
level of selective muscle activation. Lower torque in the agonist might indicate co-contraction of the antagonistic muscle, but 
only if it coincides with low selective muscle activation of that antagonist (lower left quadrant of upper right and lower left panel). 
Reversely, low torque combined with high selective muscle activation points more towards paresis of the agonist (lower right 
quadrant of upper left and lower right panel). 
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Bearing in mind that morphological changes (i.e. shortening of structures) may occur as 
early as four weeks post-stroke [45], the described neutral angle was chosen to minimize 
any influence of secondary biomechanical changes and to provide optimal conditions for 
the neural system in testing agonist and antagonist activity. Furthermore, an isometric task 
minimizes strain resulting from joint movement, allowing for isolated measurement of 
muscle activation. 
AR were specifically developed in view of potential problems with normalization when 
comparing different muscles [28]. Issues with variance in quality, quantity and control of 
muscles as outlined in the introduction, are avoided by relating the activity of the same 
muscles in different tasks. Other drawbacks of EMG based methods that researchers 
should take into account [8,46] are e.g. crosstalk and elevated background EMG activity. 
Crosstalk might be increased by using two electrodes per muscle group, but only if the 
EMG-signal is relatively silent [47]. A small amount of crosstalk from other flexors besides 
FCR during flexion or other extensors besides ECR during extension would have negligible 
consequences for the results. Elevated background EMG activity, i.e. muscle EMG-activity at 
rest in post-stroke patients [48] could theoretically lead to unjustified exclusion of patients 
with insufficient voluntary muscle activation and falsely low AR by mechanism of a lower 
ratio of activity (in-phase) to rest (out-phase) EMG. However, as elevated background EMG 
in post-stroke patients was quantified at around 3% of maximal EMG during a maximal 
voluntary contraction task [48], we assume that this had no influence on our definition of 
insufficient voluntary muscle activation and was of no clinical relevance for AR.
Future work
Objective and reproducible data such as AR support a more substantiated analysis of clinical 
phenotypes. In this light the next step is to gather longitudinal information on selective 
muscle activation to follow functional recovery of stroke patients over time [49] and to 
monitor results of treatment. Combining AR data and kinematic data could give a valuable 
insight into the connection between loss of selective muscle activation around a single joint 
(e.g. co-contraction or co-activation) and multi joint synergistic movements. Moreover, to 
help prevent under- or overtreatment and to ensure that not only the affected muscle but 
also the aims of the patient on activity and participation level are treated, knowledge on 
the relation between selective muscle activation and functional outcome is essential in the 
future design of treatment paradigms for post-stroke patients.
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CONCLUSION
Activation Ratios allow for reliable muscle specific quantification of selective muscle 
activation in participants with sufficient voluntary muscle activity. We observed significantly 
lower Activation Ratios in the group of post-stroke patients compared to the group of 
healthy participants, which indicate loss of selective muscle activation in post-stroke 
patients. Information on loss of selective muscle activation will allow clinicians to improve 
clinical decision making, follow patients over time and monitor results of treatment.
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Supplementary Figure S1 | Limb dominance.
Boxplot for both ARflex and ARext of post-stroke patients, separately depicting dominant and non-dominant side. Before this study, 
we had no data on the effect of dominance of the affected limb on selectivity of muscle activation. Our method allowed to test 
this: In our patient group, approximately half of the patients were affected (and measured) at the dominant side (Main text Table 
1). A t-test showed that there was no significant difference in muscle selectivity (AR) between post-stroke patients measured at the 
dominant side, compared to the non-dominant side. 
Supplementary Figure S2 | Influence of variance on ICC and SEM.
Group differences in reliability and heteroscedasticity were graphically represented in Bland Altman plots (Figure 6). The ICC for 
the stroke group may well be underestimated. Separate calculation of ICC and SEM per group (healthy vs stroke) would increase 
the ICC for post-stroke patients, as ICC are the between-measurements variance expressed as a proportion of the total variance. 
Variance in the stroke group is large (as can be seen in Figure 4), leading to higher ICC’s. Variance in the healthy group is smaller, 
leading to lower ICC. SEM’s are almost unchanged when separately calculated per group (i.e. lower ICC but also lower standard 
deviation).
ICC and SEM per group are represented in this table. As can be inferred from the 95%CI of the ICC’s there is no significant difference 
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ABSTRACT
In stroke patients, pathophysiological mechanisms of functional recovery are largely 
unknown. The aims of this study were to quantify neural and non-neural contributors to 
endpoint wrist joint behavior under both passive and active task conditions, and to relate 
these neuromechanical parameters to the recovery of arm-hand function.
Methods
Wrist neuromechanical parameters (measured with haptic robotics and surface electro-
myography) and Action Research Arm Test (ARAT) were assessed prospectively in 36 stroke 
patients on 8 occasions during the first 6 months after stroke. At 6 months, maximum 
voluntary contraction, passive stiffness at rest angle and reflex modulation were related 
to ARAT by linear regression. Predictors of positive functional outcome (ARAT ≥ 10) were 
determined by a repeated measures model.
Results
At 6 months after stroke, a lower maximum voluntary contraction and impaired reflex 
modulation were significantly related to poor functional outcome (p < 0.001 and p = 0.047). 
A steady rest angle and increasing active range of motion contributed most to prediction of 
positive functional outcome.
Conclusion
Longitudinally measured neuromechanical parameters relate to arm-hand function during 
the first 6 months after stroke and, as a reflection of pathophysiological dynamics of 
recovery, may assist clinicians in triage and assignment of optimally individualized therapy.
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INTRODUCTION
Impairment in function of the upper extremity is common after stroke [1,2] and has a 
profound impact on activities and participation in daily life [1,3-5]. Despite an increased 
attention for measuring outcome on multiple levels of the International Classification of 
Functioning, Disability and Health (ICF), the relationship between pathophysiological 
mechanisms of recovery and functional outcome as measured with clinical scales, is 
still largely unknown [6-8]. Furthermore, the relationship between pathophysiological 
mechanisms of recovery and time after stroke is still uncharted territory, as longitudinal 
data in the acute phase after stroke are still scarce [9,10].
In translational research, the connection between pathophysiological changes and 
functional outcome is typically addressed by relating neural imaging techniques (e.g. 
functional MRI, transcranial magnetic stimulation) and movement analysis (e.g. kinematics) 
to clinical scales [11] on the ICF-levels of impairment (e.g. Fugl Meyer Assessment), 
activity (e.g. Action Research Arm Test (ARAT), Motor Activity Log) and participation (e.g. 
Health Related Quality of Life). Neuromechanics [12] may contribute to this framework of 
assessments by providing a quantitative high resolution assessment of neural and non-
neural contributors to endpoint joint behavior under passive and active conditions and 
as a reaction to external mechanical perturbations [13-15] by use of biomechanical and 
neurophysiological techniques [6,16]. Measuring neuromechanical parameters around a 
single joint excludes interference of compensatory movements as seen in multi-joint tasks. 
Previous studies in stroke indicate a large contribution of paresis, stiffness and a decreased 
ability to modulate reflexes in a changing environment to poor functional outcome 
[6,14,16-20]. To further explore this, a longitudinal study was conducted. We hypothesize 
that a poor functional outcome (less than 10 points on ARAT at 6 months after stroke [11]) 
is associated with a more pronounced paresis, a higher degree of stiffness and absence 
of reflex modulation at 6 months post stroke. Furthermore, using our earlier described 
comprehensive neuromechanical assessment protocol [21], we systematically describe the 
course of passive, active and reflexive parameters at the wrist joint during the first 6 months 
after stroke and, with this information, identify neuromechanical predictors of functional 
outcome. 
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METHODS
Participants
This study was conducted as an observational study within the EXplaining PLastICITy after 
stroke trial (EXPLICIT-stroke, Dutch Trial register NTR1424, part B3). EXPLICIT-stroke is a 
multicenter research program, consisting of a randomized clinical trial on the effects of early 
rehabilitation intervention on arm-hand function after stroke and a longitudinal survey into 
the dynamics of post-stroke recovery [11]. Participants were assessed for eligibility within 
one week after stroke according to the following criteria: first-ever ischemic stroke in area of 
middle cerebral artery; impairment of the arm (National Institutes of Health Stroke Severity 
(NIHSS) item 5a or 5b score 1 – 4); age 18 to 80 years; able to travel to Leiden University 
Medical Center (LUMC) or University Medical Center Utrecht (UMCU).
Participants were excluded in case of previous upper extremity orthopedic limitations 
on affected side; insufficient communication (Utrecht Communication Observation item 
19: score less than 4 points ) [22]; and/or severe cognitive impairment (Mini Mental State 
Examination: score 22 points or less) [23]. Participants were then stratified into 2 prognostic 
groups according to National Institutes of Health Stroke Severity (NIHSS) item 5a or 5b; 
group F with a favorable prognosis (score 1 – 2) and group U with an unfavorable prognosis 
(score 3 – 4). The study was approved by the Medical Ethical Committees of the LUMC and 
UMCU. Written informed consent was given by all participants in the first week after stroke. 
All participants started with inpatient rehabilitation and were discharged home as soon as 
this was safe. This was followed by ambulant/outpatient rehabilitation according to usual 
care. In addition to usual care, the intervention therapies of the main trial were applied 
according to stratification (favorable prognosis: modified Constrained Induced Movement 
Therapy; unfavorable prognosis: electromyography-triggered Neuromuscular Stimulation) 
and randomization. Participants were compensated for travel expenses.
Measurement set up and protocol
Measurements consisted of a neuromechanical assessment protocol and the ARAT, which 
were administered on eight occasions at fixed time points within the first 6 months after 
stroke: weekly in the first 5 weeks after stroke and subsequently at 8, 12 and 26 weeks 
after stroke. The neuromechanical assessment protocol was performed at the department 
of Rehabilitation at the LUMC and UMCU. A haptic robot (Wristalyzera) delivered precise 
torque or position perturbations to a handleb via a vertically positioned servomotora. 
Muscle activity of m. flexor carpi radialis and m. extensor carpi radialis brevis and longus was 
recorded by a surface EMG-systemc. Participants were seated upright in front of a screen, 
with their hand fixed to the handle. The handle had an ellipsoidal shape to prevent finger 
flexion (Figure 1). The arm and elbow were stabilized in an arm rest. The motor axis was 
aligned with the rotation axis of the wrist joint, therefore rotation of the motor was directly 
103Longitudinal study | 
6
coupled to flexion/extension movement of the wrist. Participants were provided with visual 
feedback on torque, angle or EMG-level, depending on the task instruction.
Each test within the measurement protocol was aimed at quantification of either non-neural 
contributors (passive parameters) or neural contributors (active and reflexive parameters) 
to movement disorder after stroke. Passive parameters were measured at low velocity to 
minimize muscle activation and stretch reflexes, and included a task instruction to “do 
nothing”. Measurement of active parameters included task instructions to “move/push/
hold”, i.e. exert a voluntary torque or complete a prescribed movement trajectory. Reflexive 
parameters were measured at higher wrist rotation velocities, to elicit reflexes, with either 
passive or active task instructions [24]. Measurements took 45 minutes.
Observers of neuromechanical parameters (HK and AK) and ARAT (RN) were blinded for 
each other’s outcome.
Data analysis
Data were retrieved and processed with customized software written in Matlab 2007bd. The 
following neuromechanical parameters were extracted [24]:
Passive parameters:
 – Passive Range of Motion (PROM): range between maximal flexion and extension wrist 
angles during a slow sinusoidal passive movement with a maximal torque of 2 Nm.
 – Rest Angle (PRA): angle within passive range of motion where the angle-torque curve 
crosses 0 Nm, during a slow, position controlled, passive movement.
 – Stiffness in Rest (Pk): resistance to passive movement during a slow, position controlled, 
passive movement through passive range of motion. The average negative tangent of 
the angle-torque curve over 0.2 rad around PRA was calculated.
Active parameters:
 – Active Range of Motion (AROM): range between maximal flexion and extension wrist angles 
obtained during a voluntary movement through range of motion without external 
resistance. 
 – Maximal Voluntary Contraction (AMVC): maximal isometric torque generated by 
participants in direction of flexion (AMVC flex) and extension (AMVC ext). The handle of the 
haptic robot was fixed at the Rest Angle (PRA). 
 – Control over Joint Torque (ACJT): ability of participant to achieve steadily increasing target 
torque in direction of flexion (ACJT flex) and extension (ACJT ext). The handle of the haptic 
robot was fixed at PRA.
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Figure 1 | Illustration of Wristalyzer handle and arm-rest. 
For a better view of the hand position, the hand straps are not represented in this illustration.
Reflexive parameters:
 – Reflexive Loop Time (Rlt): time from start of ramp and hold perturbation to short latency 
reflex onset. Participants were asked either to relax (“do nothing”) (Rlt pas) or to deliver 
10% of maximum EMG-activity as measured during AMVC (Rlt act). Perturbations consisted 
of position controlled angular displacements over 0.14 rad at a velocity of 2 rad/s.
 – Reflex Magnitude (RAUC): area under EMG-time curve in window of 0.02 – 0.05s after 
perturbation. Participants were asked either to relax (“do nothing”) (RAUC pas) or to deliver 
10% of maximum EMG-activity as measured during AMVC (RAUC act). Perturbations consisted 
of position controlled angular displacements over 0.14 rad at a velocity of 2 rad/s. EMG 
was normalized, rectified and low pass filtered (80Hz Butterworth).
 – Reflexive Contribution to Joint Resistance (Rkv): participants were asked to resist fast 
multisine force perturbations (“hold position”). Velocity dependent reflex gain was 
computed using system identification methods [25].
 – Reflex Modulation due to Environmental Changes (Rm_env): participants were asked to resist 
fast multisine force perturbations (“hold position”) in a damped environment (i.e. a 
viscous environment was simulated by the haptic robot). Velocity dependent reflex gain 
in this altered environment was computed [17].
Parameter changes over time were separately analyzed for three groups of participants, 
defined on both initial prognosis: group F with a favorable prognosis (NIHSS item 5 score 
1-2) and group U with an unfavorable prognosis (NIHSS item 5 score 3 – 4); and functional 
outcome post stroke: ARAT ≥ or < 10 points at 26 weeks [11]. This led to the following groups: 
favorable prognosis-positive functional outcome (F-positive); unfavorable prognosis-positive 
functional outcome (U-positive) and unfavorable prognosis-poor functional outcome (U-poor).
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Statistical analysis
Parameters were inspected for normality of distribution. The relation between stiffness 
(Stiffness in Rest = Pk) at 26 weeks and positive functional outcome (i.e. ARAT ≥ 10 at 26 
weeks) was described by linear regression. The same applied for paresis (Maximal Voluntary 
Contraction = AMVC flex) and reflex modulation (Reflex Modulation due to Environmental 
Changes = Rm_env). 
Changes over time and between groups were visually inspected and screened per parameter 
by a generalized estimating equation with the outcome group (F-positive, U -positive, U-poor) as a 
between participants factor and time as a within participants factor, and the interaction of 
time with outcome included in the model. Post-hoc testing per week was then performed 
by ANOVA and Tukey (or Dennett when parameters were not equally distributed per group 
as tested with Levene’s test).
To determine predictors of a positive functional outcome on the ARAT, a multivariate 
repeated measures model was fitted by means of a generalized estimating equation. Within 
this model, the stratified group (F- or U-group) was modeled as a factor, and time (i.e. # 
weeks after stroke) was modeled as a within participants factor. Descriptive parameters 
(age, affected hand and gender) and outcome parameters (PROM, Pk, PRA, AROM, AMVC, ACJT, Rlt, 
RAUC, Rkv, Rm_env) were added stepwise. Statistics were performed in SPSS Statistics 20
e.
RESULTS
Out of an eligible cohort of 68 patients, 36 participants were included between April 1th 
2009 and March 1th 2012: 15 participants were stratified into the F-group and 21 participants 
were stratified into the U-group. A description of the study population is presented in Table 
1. Due to medical factors associated with stroke (e.g. fatigue, co-morbidity) and logistic 
difficulties inherent to a multicenter trial (e.g. transport of participants between facilities), 
41 out of 288 scheduled visits were cancelled. Sixty visits were missed because of late 
enrollment; participants were enrolled in EXPLICIT-stroke, but could not participate in part 
B3 yet, due to location or co-morbidity. An additional 20 visits were cancelled on account 
of loss to follow up. With an average of 4.7 visits per participant (SD 1.9) in the F-group and 
4.6 (SD 1.9) in the U-group, participation in both groups was comparable (p = 0.941, 95% 
confidence interval -1.2 to 1.3 visits) (Figure 2 Flow Diagram).
All 15 participants in the group with an initial favorable prognosis (F-group) achieved a 
positive functional outcome of an ARAT score of 10 points or higher at 26 weeks (F-positive). In 
the group with an initial unfavorable prognosis (U-group), 12 participants (57%) achieved 
an ARAT of 10 or higher (U-positive) and 9 participants did not (43%) (U-poor).
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Table 1 | Descriptive data of the study population.
Overall descriptive data and separate descriptives per group. Groups based on prognosis (NIHSS score item 5) and functional 
outcome (Action Research Arm Test): F-positive: favorable prognosis-positive functional outcome; U-positive: unfavorable prognosis-
positive functional outcome, and U-poor: unfavorable prognosis-poor functional outcome. All variables presented as n (%), unless 
otherwise indicated. IQR: interquartile range.
Overall F-positive U-positive U-poor
Participants 36 15 12 9
Age, years (mean, (SD)) 59.8 (10.6) 60.7 (8.2) 59.6 (14.6) 58.6 (8.6)
Gender (male) 27 (75) 12 (80) 8 (67) 7 (78)
Hand preference: right hand 30 (83) 13 (87) 11 (91) 7 (78)
Affected hand: right hand 12 (33) 3 (20) 5 (42) 4 (44)
Affected hand = preferred hand 10 (28) 4 (27) 4 (33) 2 (22)
ARAT week 1 (median [IQR]) 9 [6 – 31] 0 [0 – 0] 0 [0 – 0]
ARAT week 26 (median [IQR]) 40 [38 – 57] 39 [31 – 53] 0 [0 – 3]
Functional outcome related to stiffness, paresis and reflex modulation
At week 26, Pk was not significantly related to functional outcome (p = 0.940; Standard Error 
of the Estimate (SE) 0.055) (Figure 3 top panel). AMVC flex at 26 weeks did have a significant 
relation with functional outcome (Figure 3 middle panel): participants that did not reach 
10 points on the ARAT at 26 weeks produced less torque compared to participants with 
an ARAT score ≥ 10 points at 26 weeks (p < 0.001; SE 0.391). Rm_env at 26 weeks had a less 
outspoken, but still significant relation with functional outcome (p = 0.047; SE 0.005). In 
participants that did not reach 10 points on the ARAT, the ability for reflex modulation was 
diminished (Figure 3 lower panel).
Longitudinal changes
In the first 6 months after stroke, PROM, PRA, AROM, AMVCflex , AMVCext, ACJTflex, ACJText, and RAUCactflex 
had a significant change in outcome over time and/or between groups as tested with the 
generalized estimating equation and post-hoc test with ANOVA and Tukey or Dennett. The 
time course of these parameters is illustrated in Figure 4 and Table 2.
In the F-positive group, passive parameters did not change over time. Active parameters 
recuperated most before week 4. On average, maximal voluntary contraction (AMVC) and 
control over joint torque (ACJT) at week 26 did not recover to values measured in healthy 
volunteers [21]. Reflexive parameters demonstrated small reflex magnitudes and an ability 
to modulate reflexes in a changing environment.
The U-positive group showed no change in passive parameters except for a reduction in passive 
range of motion (PROM). Active parameters recuperated, but at a later moment in time than 
observed in the F-positive group. The ability to modulate reflexes in a changing environment 
(Rm_env) did not change over time. 
107Longitudinal study | 
6
The U-poor group had a marked shift in rest angle (PRA) towards flexion as early as the first week 
after stroke (this could only be quantified from week 8 onwards because of small groups/
missing values), little or no improvement in active parameters, higher reflex magnitudes 
(RAUC) and a diminished ability to modulate reflexes in a changing environment (Rm_env). 
A marked increase in AROM in the F-positive and U-positive group was observed before week 4, 
while an increase in AROM in the U-poor group was not observed until week 8. The increase in 
Maximal Voluntary Contraction (AMVC flex) in the U-group started at 5 weeks. Improvement in 
Control over Joint Torque (ACJT flex) in the U-group started at 5 weeks or later. 
Figure 2 | Flow Diagram.
Progress of participants through our observational study. Flow diagram based on CONSORT statement [26]. F-group = favorable 
prognosis, U-group = unfavorable prognosis.
Assessed for eligibility (n = 68)
Excluded
♦  Not meeting inclusion criteria (n = 32)
68 out of 120 scheduled visits
(57% ) (n=15)  
Late enrollment (n = 9; -26 visits) 
Lost to follow-up (n = 5; -10 visists);
♦ Participant declined (-10)
Missing data (n = 9; -16 visits):
♦ Location or endurance /illness
F -group (n =15)
Late enrolment ( n = 14; -34 visits)
Lost to follow-up ( n = 4; -10 visits ):
♦ P articipant declined (-7), illness (-3)
Missing data (n = 13; -25 visits):
♦ Location or endurance /illness
U-group (n = 21)




Neuromec hanics (n = 36)
























































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 2 | Analysis of changes over time and between groups per parameter. 
Group and time effect and the interaction between group and time as tested with a generalized estimating equation. Group was 
modelled as a between participants factor and time (i.e. # weeks after stroke) as a within participants factor; p-values of the Wald 
Chi Square are represented. Post-hoc analysis by ANOVA and Tukey (or Dennett when parameters were not equally distributed per 
group as tested with Levene’s test). PRA = Rest Angle, PROM= Passive Range of Motion, Pk = Stiffness in Rest, AROM = Active Range of 
Motion, AMVC = Maximal Voluntary Contraction, ACJT = Control over Joint Torque, Rlt = Reflexive Loop Time, RAUC = Reflex Magnitude, 
Rkv = Reflexive Contribution to Joint Resistance, Rm_env = Reflex Modulation due to Environmental Changes. F = F-positive group, U+ = 
U -positive group, U- = U-poor group.(continues on next page)
Parameter Generalized  
estimating equation
Post hoc analysis
  Group Time Inter-
action
Week 4 Week 5 Week 8 Week 12 Week26
PRA < 0.001  0,217 < 0.001 n.s. n.s. U-/F 0.041 U-/F 0.043 U-/F 0.007
U-/U+ 0.037




Pk 0.525 0.487 < 0.001 n.s. n.s. n.s. n.s. n.s.

























































Rlt flex pas 0.765 < 0.001 < 0.001 n.s. n.s. n.s. n.s. n.s.
Rlt ext pas 0.141 < 0.001 < 0.001 n.s. n.s. n.s. n.s. n.s.
Rlt flex act 0.660 0.001 0.002 n.s. n.s. n.s. n.s. n.s.
Rlt ext act 0.577 < 0.001 0.097 n.s. n.s. n.s. n.s. n.s.
RAUC flex act < 0.001 < 0.001 < 0.001 n.s. U-/F <0.001
U+/F <0.001
n.s. n.s. U-/F 0.012
RAUC ext act 0.501 < 0.001 0.105 n.s. n.s. n.s. n.s. n.s.
Rkv 0.199 0.076 0.009 n.s. n.s. n.s. n.s. n.s.
Rm_env 0.828 < 0.001 < 0.001 n.s. n.s. n.s. n.s. n.s.
A catch or clonus during measurements of reflexive parameters with the haptic robot was 
observed in 1 out of 12 participants in the U-positive group (8%) and 4 out of 9 participants in 
the U-poor group (44%), the earliest at week 5.
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Prediction of positive functional outcome
In the repeated measures model, descriptive parameters (age, affected hand and gender) 
were not influential. Co-linearity was observed between the active parameters AROM, AMVC 
and ACJT. Of these parameters, AROM was included in the model as most influential. RAUC was 
identified as a confounder for Pk, and therefore kept in the model, although not reaching 
significance. Therefore, the definitive model included passive parameters Pk and PRA; 
active parameter AROM; and reflexive parameters Rm_env and RAUC. Quasi Likelihood under 
Independence Model Criterion (QIC) of the definitive model was 50 (in a smaller-is-better 
format). Adding more parameters worsened the QIC, while not altering beta-coefficients 
and p-values of parameters mentioned above.
From this model it can be concluded that a steady PRA and an increasing AROM were the best 
predictors of reaching a score of 10 points or higher at the ARAT at 26 weeks after stroke 
(p 0.039 and p < 0.001 respectively), but only when outcomes of the reflexive parameters 
Rm_env and RAUC were included in the model. See Table 3 for model parameters and confidence 
intervals.
Table 3 | Repeated measures model.
To identify predictors of a positive functional outcome (ARAT ≥10 (per week), a multivariate repeated measures model was fitted 
by means of a generalized estimating equation. Within this model, the stratified group (F- or U-group) was modeled as a between 
participants factor, and time (i.e. # weeks after stroke) was modeled as a within participants factor. Parameters were added 
stepwise. 
F-group = favorable prognosis, U-group = unfavorable prognosis. PRA = Rest Angle, AROM = Active Range of Motion, RAUC = Reflex 
Magnitude, Rm_env = Reflex Modulation due to Environmental Changes. * significant p<0.05 
†F is set to zero because this is the 
reference category, i.e. functional outcome of U-group is compared to F-group. Wrist flexion angles were defined as negative 
angles.
Parameter Beta Std. Error 95% Wald Confidence 
Interval
Hypothesis Test
Lower Upper Wald Chi-Square df p-value
(Intercept) 0.293 1.3829 -2.418 3.003 0.045 1 0.832
F- group 0†
U- group -3.378 1.8903 -7.083 0.327 3.192 1 0.074
PRA 0.040 0.0194 0.002 0.078 4.257 1 0.039*
AROM 0.046 0.0131 0.021 0.072 12.510 1 0.000*
RAUC -0.657 4.2594 -9.006 7.691 0.024 1 0.877
Rm_env 1.369 3.3986 -5.292 8.030 0.162 1 0.687
(Scale) 1
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DISCUSSION
As hypothesized, paresis and diminished ability to modulate reflexes (quantified by reduced 
AMVC and lower Rm_env) were significantly related to poor functional outcome (ARAT less than 
10 points at 26 weeks after stroke). Stiffness (Pk at rest angle), was not significantly related 
to poor outcome.
Repeated measurements with a neuromechanical assessment protocol in this cohort of 
acute stroke patients showed changes in two out of three passive parameters, changes in 
active parameters even before week 4, and small to no changes in reflexive parameters.
A steady rest angle (PRA) and an increasing active range of motion (AROM) were the best 
predictors for functional outcome at 26 weeks after stroke (ARAT ≥ 10 points).
Clinical implications
In this study, changes in tissue properties in the U-group with a poor functional outcome 
(U-poor group) were represented by a shift in rest angle (PRA) and passive range of motion 
(PROM), and not by a change in stiffness in rest (Pk). Apparently, when objectively measuring 
these separate properties under standardized measurement conditions, shortening of 
elastic structures is represented by a shift in operating point (rest angle) and a limitation 
in the movement trajectory (passive range of motion). This is supplementary to previous 
findings [27,28].
Functional recovery in the group with an initial unfavorable prognosis is first heralded by 
an increase in active range of motion. It should be noted that recovery in time can differ 
between patients and it may take at least 5 – 8 weeks for an increase in active range of motion 
to become apparent in patients with an initial unfavorable prognosis. This is in accordance 
with earlier published research [9,10]. A marked shift in rest angle towards flexion is apparent 
from the start in the group with an initial unfavorable prognosis. These combined outcomes 
lead to the recommendation of regular (e.g. weekly) measurements of AROM, PROM and rest 
angle in the first 8 weeks after stroke, ideally in a standardized environment.
Strengths and limitations
Studies on longitudinal assessment in the acute phase after stroke are scarce. We 
comprehensively and prospectively assessed neuromechanics by means of passive, active 
and reflexive parameters at fixed time points after stroke with a validated neuromechanical 
assessment protocol [21] and related them to functional outcome in a stratified cohort 
of stroke patients in the early phase after stroke. Despite all efforts to complete all visits, 
missing data were unavoidable and occurred predominantly in the early phase after stroke. 
Due to the stratification based on early prediction of outcome the effects of selection bias 
were limited.
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Division in passive and active parameters was based on task instructions. This facilitates 
clinical assessment and interpretation of parameters, yet does not absolutely discriminate 
between tissue properties and motor unit recruitment [28,29], as involuntary motor unit 
recruitment may also be present at rest when measuring passive parameters (e.g. elevated 
baseline activation). Also, reflex magnitude measurement was calculated relative to the 
baseline EMG of the participant. Some underestimation of stretch reflex activation might 
therefore be expected [29]. Possible variance in EMG caused by daily fluctuations in reflex 
thresholds may introduce additional variance in reflexive parameters. Sophisticated system 
identification techniques are required to further discriminate neural and non-neural 
contributors to movement disorder after stroke, e.g. to discern baseline activity from 
reflexive activity [29,30].
CONCLUSION
In this observational study, longitudinally measured neuromechanical parameters 
were combined with data on arm-hand function after stroke. Paresis (i.e. low maximal 
voluntary contraction) and a diminished ability to modulate reflexes are associated with 
poor functional outcome at 6 months after stroke. Changes in tissue properties were 
represented by a shift in wrist rest angle towards flexion and a decline in passive range 
of motion, rather than by passive stiffness measured around the rest angle. Passive, active 
and reflexive neuromechanical parameters significantly changed over time and showed 
group effects based on favorable/unfavorable prognosis versus positive/poor functional 
outcome 6 months after stroke. An increase in active range of motion and a steady rest 
angle contributed most to prediction of functional outcome at 6 months after stroke. These 
neuromechanical parameters show potential as biomarkers for prediction of arm-hand 
function after stroke and may contribute to the translation of neural repair at the level of 
body function and structures to recovery on the level of activities and participation.
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The aim of this thesis was to explore the neuromechanics of recovery of arm-hand function 
after stroke by assessing neural and non-neural contributors to movement disorders in the 
acute and chronic phase after stroke. Key questions were: How and to what extent does 
endpoint wrist joint behavior, as measured with neuromechanical parameters, change in 
the first 6 months after stroke? And how do those changes relate to functional outcome? 
For this purpose, an assessment protocol with valid and sensitive parameters had to be 
developed, based on clear pathophysiological concepts. With the assessment protocol, a 
prospective study with repeated measurements of neuromechanical parameters in the first 
6 months after stroke was conducted.
Developing a neuromechanical assessment protocol
A literature review revealed a number of initiatives to quantify and objectify movement 
disorders after stroke. In 19 out of the 37 articles describing the use of biomechanical 
and/or EMG outcome measures to analyze post-stroke movement disorder, the authors 
strived to separate neural contributors (motor control and stretch reflexes) from non-neural 
contributors (tissue properties). The most frequently used pathophysiological constructs 
were spasticity, muscle tone and muscle overactivity. However, definitions of these constructs 
were not uniform and the distinction between neural and non-neural contributors to 
movement disorders after stroke was not commonplace yet. Only 6 of the articles measured 
biomechanical and electromyographical outcome measures simultaneously, while applying 
the active and passive tasks and multiple movement velocities necessary to separate neural 
and non-neural contributors to movement disorders after stroke (chapter 2).
The overview of pathophysiological constructs and required measurement conditions 
generated a methodology to assess endpoint joint behavior around a single axis. This 
methodology was translated into a comprehensive assessment protocol to quantify 
endpoint wrist joint behavior i.e. motor control, stretch reflex properties and tissue 
properties during flexion-extension movement under different task instructions and with 
different external perturbations, resulting in passive, active and reflexive neuromechanical 
parameters (chapter 3).
The neuromechanical parameters were responsive to clinical status, i.e. results demonstrated 
differences between a cohort of healthy participants and a cohort of chronic stroke patients. 
Test-retest reliability was assessed: passive and active parameters could be assessed with 
excellent reliability. The passive parameter rest angle and all but one of the reflexive 
parameters had fair to good reliability (chapter 4).
Evaluation of selective muscle activation by means of Activation Ratios (AR) of flexor 
carpi radialis (FCR) and extensor carpi radialis communis (ECR) was supported by high 
measurement reliability in participants with any voluntary muscle activation. AR were 
significantly lower in chronic stroke patients compared to healthy participants, indicating 
loss of selective muscle activation in the chronic stroke patients. Based on the ability for 
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voluntary muscle activation and selective muscle activation, three clinical phenotypes were 
confirmed, i.e. patients with flaccid paresis and therefore insufficient voluntary muscle 
activation to determine selective muscle activation; patients with some loss of selective 
muscle activation; and patients with selective muscle activation comparable to healthy 
volunteers, despite not reaching maximum voluntary torque comparable to healthy 
volunteers (chapter 5).
Neuromechanical parameters in the first 6 months after stroke
In the longitudinal study, neuromechanical parameters were repeatedly assessed with the 
comprehensive assessment protocol in the first 6 months after stroke in the two groups 
stratified within the EXPLICIT-stroke trial according to the finger extension algorithm [1]. In 
the group of patients with an initial favorable prognosis for recovery of arm-hand function, 
passive parameters did not change over time, while active parameters recuperated most 
before week 5. However, on average, maximal voluntary contraction and control over joint 
torque at week 26 did not recover to values measured in healthy volunteers. Reflexive 
parameters demonstrated small reflex magnitudes and an ability to modulate reflexes in a 
changing environment.
In patients with an initial unfavorable prognosis for recovery of arm-hand function, two 
subgroups could be distinguished: those with a positive functional outcome (≥10 points on 
the Action Research Arm Test (ARAT) at 6 months) and those with a poor functional outcome 
(ARAT <10 points) [2]. In the group with an initial unfavorable prognosis and a positive 
functional outcome, there was no change in passive parameters except for a reduction in 
passive range of motion. Active parameters recuperated, but at a later moment in time than 
observed in the group with an initial favorable prognosis. The ability to modulate reflexes 
in a changing environment did not change over time. In patients with an initial unfavorable 
prognosis and a poor functional outcome, there was a marked shift in rest angle towards 
flexion as early as the first week after stroke, little or no improvement in active parameters, 
higher reflex magnitudes and a diminished ability to modulate reflexes in a changing 
environment. Moreover, if there was any increase in function, it was not observed until week 
5-8. A catch or clonus during measurements of reflexive parameters was only observed in the 
groups with an initial unfavorable prognosis, in 8% of participants with a positive functional 
outcome and in 44% of participants with an poor functional outcome, the earliest at week 
5 (chapter 6).
The relation between neuromechanical parameters and functional outcome
All participants with an initial favorable prognosis for recovery of arm-hand function after 
stroke reached a positive functional outcome of ARAT ≥10 points at 26 weeks. Within the 
group of patients with an unfavorable prognosis for functional outcome, 57% reached 
a positive functional outcome at 26 weeks. A diminished ability for maximal voluntary 
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contraction and a diminished ability to modulate reflexes at 26 weeks were significantly 
related to poor outcome. Stiffness (as measured around the rest angle) at 26 weeks was not 
significantly related to poor outcome. However, structural changes in tissue properties were 
represented by a changed rest angle towards wrist flexion and a diminished passive range 
of motion. Prediction of functional outcome on activity level was mostly determined by an 
increase in active range of motion and a stable rest angle (chapter 6).
Clinical implications
The precision diagnostics provided by a neuromechanical assessment protocol could 
support clinical decision making. To enhance prediction of recovery of arm-hand function 
after stroke and better represent endpoint joint behavior [3,4], neuromechanical parameters 
could be added to the current set of biomarkers of stroke recovery [5]. Furthermore, 
implementation of the use of neuromechanical parameters such as selective muscle 
activation, rest angle and active range of motion in future intervention trials concerning 
e.g. botulinum toxin, surgery or robot therapy will support both stratifying the patients 
most likely to benefit from an intervention and evaluating the results of a given therapy in 
a more objective manner. Moreover, neuromechanical parameters allow for a connection 
to be made between pathophysiology and treatment goals within the framework of the 
International Classification of Functioning, Disability and Health (ICF) [6]. 
To achieve an improvement in activities or participation, it is sometimes, but not always, 
necessary to intervene at the level of body functions and structures first. This decision 
should be based on clear patient-related information concerning which pathophysiological 
entity is most constraining for arm-hand function at that moment in time and in the context 
of a prediction model. For example, to optimize the period in which neural repair is possible 
and prevent secondary complications, neuromechanical parameters such as rest angle and/
or active range of motion could be monitored systematically in the first months after stroke 
and treatment adapted accordingly. In the group of patients with a favorable prognosis 
for recovery of arm-hand function, active task oriented training can start right away, while 
in patients with an unfavorable prognosis, the focus should be on passive movement to 
prevent contractures until there is an increase in active range of motion (which can take 
up to 5-8 weeks after stroke). If there is no improvement in active function after 5-8 weeks, 
compensation strategies should be considered [7] and efforts to prevent contractures can 
be monitored by repeated assessment of rest angle.
Methodological considerations
The neuromechanical assessment protocol aimed to identify neural and non-neural 
contributors to movement disorders by differences in task and measurement conditions. For 
example: the protocol was designed to minimize the effects of neural contributors during 
non-neural tasks and vice versa. However, this might not yet give a complete reflection 
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of endpoint joint behavior, as system behavior under active task conditions involves 
a combination of both neural and non-neural contributors. The same goes for passive 
conditions, where neural contributors may be present through increased baseline activation 
[8]. Further development of System Identification and Parameter Estimation techniques 
might help to differentiate even better between neural and non-neural contributors to 
movement disorders after stroke, e.g. further differentiation between passive and reflexive 
stiffness [9].
The studies in this thesis refer to wrist function, a single axis joint function. This could do 
injustice to arm-hand function in general when not connected to outcome measures on the 
level of activity or participation. On the other hand, the limitation in freedom of movement 
gives us a unique insight in function without synergies and compensatory trunk movement.
Stratification of patient groups makes it more difficult to generalize the results to the stroke 
population as a whole; however, as stratification contributes to an increased homogeneity 
within the subgroup and an increased heterogeneity between subgroups, interpretation 
of the results in our study is greatly ameliorated by stratification according to the finger 
extension algorithm [10,11].
Future work 
As the comprehensive neuromechanical assessment protocol is only used in a research 
setting so far, future work should include implementation of the protocol in daily practice. 
Further research into e.g. the amount of training needed for caregivers to apply the protocol 
and the applicability of the protocol in the general stroke population could help remove 
the behavioral and economical barriers often seen in implementation of robot-assisted 
assessments [12]. Interpretation of the results could be enhanced by developing a flowchart 
containing distinctive neuromechanical parameters for different patient categories 
and treatment questions. To assemble such a flowchart, systematic measurement of 
neuromechanical parameters should be incorporated in intervention trials, to answer e.g. 
the following questions:
 – Can a shift in rest angle be prevented? For example by passive (possibly robot assisted) 
movement, splinting, oral spasmolytics or botulinum toxin?
 – If a shift in rest angle is prevented, does this help in recovery of arm-hand function?
 – In the presence of selective muscle activation and a suboptimal maximal voluntary 
contraction, is an exercise program aimed at strength beneficial in recovery of arm-hand 
function? 
 – Does botulinum toxin have an effect on active range of motion or on arm-hand function 
in terms of activity or participation if there is no selective muscle activation? 
 – How can additional therapy (e.g. splinting, passive movement) maximize the possible 
effect of botulinum toxin on passive range of motion and/or stiffness? Can additional 
therapy help to prevent a relapse once the effect of botulinum toxin wanes?
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 – If there is no selective muscle activation in a transposed muscle, is surgery aimed at 
creating a functional joint beneficial?
 – Are neural contributors to movement disorders after stroke a risk for pressure sores or 
even losing the desired position of the joint after surgery to stabilize a joint?
 – Which stretch reflex properties help in selecting patients for surgery aimed at 
interruption of the stretch reflex loop?
These examples may seem very plain, but objective and reproducible assessment of neural 
and non-neural contributors to movement disorders after stroke are not commonplace yet. 
Neuromechanical parameters should be used in prediction models and as biomarkers to 
support clinical decision making in recovery of arm-hand function after stroke, for example 
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Een cerebrovasculair accident of een beroerte wordt door de Wereldgezondheidsorganisatie 
gedefinieerd als “een onderbreking van de bloedtoevoer naar de hersenen, meestal omdat 
een bloedvat scheurt of wordt geblokkeerd door een stolsel. Dit blokkeert de toevoer van 
zuurstof en voedingsstoffen en veroorzaakt schade aan het hersenweefsel”. De effecten 
van een beroerte hangen af van welk deel van de hersenen betrokken is en hoe ernstig de 
schade is. Slechts 10% van de patiënten met een beroerte heeft een volledig functioneel 
herstel en 15 % overlijdt aan de gevolgen van de beroerte. Tussen de 32% en 60% van 
de patiënten ervaart een blijvende beperking van de arm-handfunctie, met als gevolg 
beperkingen in activiteiten van het dagelijks leven of in participatie in de samenleving, 
zoals sociale activiteiten, sport of werk.
Interventies gericht op het herstel van de arm-handfunctie zijn ofwel gericht op herstel van 
hersenweefsel en -functie of op compensatiemethoden en het voorkomen van secundaire 
complicaties zoals contracturen. Therapieën zijn vaak duur en tijdrovend voor zowel 
patiënten als therapeuten. De doelmatigheid van therapieën kan worden verbeterd door 
het selecteren van het juiste moment en de juiste patiënt voor een bepaalde interventie. 
Voorspellingsmodellen en biomarkers kunnen de klinische besluitvorming op dit gebied 
ondersteunen. Maar de huidige voorspellingsmodellen en biomarkers maken nog 
onvoldoende gebruik van informatie over factoren die de uiteindelijke beweging van een 
gewricht bepalen, zoals weefseleigenschappen, de controle over aanspanning van spieren 
en reflexeigenschappen. Klinisch wordt de uiteindelijke beweging van een gewricht meestal 
beschreven in termen als parese en spasticiteit en gemeten door lichamelijk onderzoek. 
Bewegingsstoornissen na een beroerte zijn het resultaat van een complexe interactie 
tussen neurale ontregeling en veranderingen in weefseleigenschappen, leidend tot een 
herkenbaar beeld van spierzwakte (parese), spier-overactiviteit en contracturen. Parese 
wordt bepaald door verminderde vrijwillige aanspanning van spieren. Overactiviteit wordt 
bepaald door toegenomen onvrijwillige aanspanning van spieren. Contracturen worden 
gekenmerkt door veranderde weefseleigenschappen en een veranderde positie van het 
gewricht. Met behulp van neuromechanica wordt een kwantitatieve beschrijving mogelijk 
van de factoren die de uiteindelijke beweging van een gewricht bepalen, onder passieve 
en actieve omstandigheden en als reactie op externe mechanische verstoringen. Door 
het toepassen van verschillende meetcondities en taken kunnen weefseleigenschappen, 
controle over aanspanning van spieren en reflexeigenschappen apart gemeten worden. Het 
toepassen van verschillende meetcondities en taken en een reproduceerbare, objectieve 
vastlegging van de resultaten wordt mogelijk gemaakt door biomechanische technieken 
(die gebruik maken van haptische robots, meetinstrumenten met krachttransducers en 
elektrogoniometers) in combinatie met elektromyografie.
Het doel van het onderzoek in dit proefschrift was het beschrijven van de veranderingen 
in neuromechanica bij het herstel van arm-handfunctie na een beroerte, door het in 
kaart brengen van weefseleigenschappen, controle over aanspanning van spieren en 
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reflexeigenschappen in de acute en chronische fase na een beroerte. Hoofdvragen 
waren: Hoe en in welke mate veranderen de factoren die de uiteindelijke beweging van 
het polsgewricht bepalen, beschreven in neuromechanische parameters, in de eerste zes 
maanden na een beroerte? En hoe verhouden deze veranderingen zich tot de functionele 
uitkomst? Voor dit doel moest een meetprotocol met valide en nauwkeurige parameters 
worden ontwikkeld, gebaseerd op eenduidige pathofysiologische concepten. Op basis 
van dit protocol werd een prospectieve studie uitgevoerd, waarin patiënten de eerste zes 
maanden na een beroerte werden gevolgd en de neuromechanische parameters werden 
gemeten. De studies in dit proefschrift werden uitgevoerd in het kader van de Explaining 
PLastICITy trial (EXPLICIT-stroke). Dit multicenter onderzoeksprogramma bestond uit 
een gerandomiseerde klinische studie naar de effecten van vroege therapie op de 
armhandfunctie na een beroerte en een longitudinaal onderzoek naar de dynamiek van 
herstel na een beroerte.
Eerst werd door middel van literatuuronderzoek de kloof tussen de dagelijkse praktijk 
(lichamelijk onderzoek) en de mogelijkheden van biomechanische en elektrofysiologische 
technieken in kaart gebracht. Dat resulteerde in een overzicht van regelmatig gebruikte 
pathofysiologische concepten en biomechanische en elektromyografische uitkomstmaten 
van bewegingsstoornissen na een beroerte (hoofdstuk 2).
Het overzicht van pathofysiologische concepten en vereiste meetcondities genereerde een 
methode om de bewegingen van een gewricht rond een enkele as te beoordelen. Deze 
methode werd vertaald in een uitgebreid meetprotocol om de factoren te kwantificeren die 
de uiteindelijke beweging van het polsgewricht bepalen. Weefseleigenschappen, controle 
over aanspanning van spieren en reflexeigenschappen werden bepaald tijdens flexie-
extensiebewegingen van de pols onder verschillende taakinstructies en met verschillende 
externe verstoringen, resulterend in passieve, actieve en reflexieve neuromechanische 
parameters (hoofdstuk 3).
Test-hertestbetrouwbaarheid van het nieuw ontwikkelde protocol werd beoordeeld 
en er werd berekend of er verschillen aangetoond konden worden tussen een groep 
patiënten in de chronische fase na een beroerte met een verminderde arm-handfunctie 
en een groep gezonde deelnemers. De neuromechanische parameters verschilden tussen 
de gezonde deelnemers en de patiënten in de chronische fase na een beroerte. De test-
hertestbetrouwbaarheid van passieve en actieve parameters was uitstekend. De rusthoek 
en bijna alle reflexieve parameters (op één na) hadden een redelijke tot goede test-
hertestbetrouwbaarheid (hoofdstuk 4).
De invloed van co-contractie en parese op de arm-handfunctie werd onderzocht door 
het vaststellen van stoornissen in selectieve spieractivatie. Het meten van selectieve 
spieractivatie door middel van activatieratio’s (AR) van m. flexor carpi radialis (FCR) en m. 
extensor carpi radialis (ECR) had een hoge betrouwbaarheid. De AR waren significant lager 
bij patiënten in de chronische fase na een beroerte in vergelijking met gezonde deelnemers, 
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wat wijst op verlies van selectieve spieractivatie bij patiënten in de chronische fase na een 
beroerte. Op basis van vrijwillige aanspanning van de spieren en selectieve spieractivatie 
werden drie klinische fenotypes onderscheiden: patiënten met slappe parese en derhalve 
onvoldoende vrijwillige aanspanning om selectieve spieractivatie te bepalen, patiënten 
met enig verlies van selectieve spieractivatie, en patiënten met selectieve spieractivatie 
vergelijkbaar met gezonde vrijwilligers, ondanks het niet bereiken van een maximaal 
vrijwillige kracht die vergelijkbaar is met gezonde vrijwilligers (hoofdstuk 5).
Uiteindelijk werden veranderingen in neuromechanische parameters longitudinaal 
gemeten in het prospectieve cohort van de EXPLICIT-studie. In de groep patiënten met een 
aanvankelijk gunstige prognose voor herstel van arm-handfunctie, veranderden de passieve 
parameters niet in de loop van de tijd, terwijl actieve parameters het meest herstelden vóór 
week 5. De maximale vrijwillige kracht en controle van de krachtsopbouw herstelden zich 
echter niet naar waarden zoals gemeten bij gezonde vrijwilligers. De reflexieve parameters 
lieten relatief lage reflexen zien en een vermogen om reflexen te moduleren in een 
veranderende testomgeving. Bij patiënten met een aanvankelijk ongunstige prognose voor 
het herstel van de arm-handfunctie, konden twee subgroepen worden onderscheiden: 
die met een positieve functionele uitkomst (≥ 10 punten op de Action Research Arm Test 
(ARAT) na zes maanden) en die met een slechte functionele uitkomst (ARAT <10 punten). 
In de groep met een aanvankelijk ongunstige prognose en een positieve functionele 
uitkomst was er geen verandering in de passieve parameters over de tijd, behalve een 
vermindering van de passieve range of motion. De actieve parameters herstelden, maar op 
een later tijdstip dan waargenomen in de groep met een aanvankelijk gunstige prognose. 
Het vermogen om reflexen te moduleren in een veranderende omgeving veranderde niet 
in de loop van de tijd. Bij patiënten met een aanvankelijk ongunstige prognose en een 
slechte functionele uitkomst, was er al in de eerste week na een beroerte een duidelijke 
verschuiving van de rusthoek in de richting van flexie. Daarnaast was er weinig of geen 
verbetering van de actieve parameters, waren er hogere reflexen en was er een verminderd 
vermogen om reflexen te moduleren in een veranderende omgeving. Bovendien werd 
de toename in functie, als deze er al was, pas waargenomen vanaf week 5-8. Een catch of 
clonus tijdens het meten van de reflexieve parameters werd alleen waargenomen in de 
groepen met een initiële ongunstige prognose, bij 8% van de deelnemers met een positieve 
functionele uitkomst en bij 44% van de deelnemers met een slechte functionele uitkomst, 
op zijn vroegst in week 5 (hoofdstuk 6).
Alle deelnemers met een aanvankelijk gunstige prognose voor het herstel van de arm-
handfunctie na een beroerte bereikten een positieve functionele uitkomst van ARAT ≥ 
10 punten na 26 weken. Binnen de groep patiënten met een ongunstige prognose voor 
functionele uitkomst, bereikte 57% een positieve functionele uitkomst na 26 weken. Een 
verminderde maximale vrijwillige kracht en een verminderd vermogen om reflexen te 
moduleren na 26 weken waren significant gerelateerd aan een slechte uitkomst. Stijfheid 
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(gemeten rond de rusthoek) na 26 weken was niet significant gerelateerd aan een slechte 
uitkomst. Structurele veranderingen in weefseleigenschappen waren wel zichtbaar 
door een veranderde rusthoek (meer polsflexie) en een verminderd passieve range of 
motion. Voorspelling van een positieve functionele uitkomst op activiteitenniveau werd 
grotendeels bepaald door een toename in de actieve range or motion en een stabiele 
rusthoek (hoofdstuk 6).
In de algemene discussie komen de diverse aspecten van het meten van stoornissen in 
armhandfunctie na een beroerte aan bod, inclusief klinische implicaties, methodologische 
overwegingen en aanbevelingen voor toekomstig werk (hoofdstuk 7).
CONCLUSIE
Objectieve en reproduceerbare beoordeling van de factoren die de uiteindelijke beweging 
van een gewricht bepalen na een beroerte is nog geen gemeengoed. Neuromechanische 
parameters zouden gebruikt kunnen worden in voorspellingsmodellen en als biomarkers 
om klinische besluitvorming bij het herstel van de arm-handfunctie na een beroerte te 
ondersteunen, bijvoorbeeld door het verbeteren van de selectie van patiënten en van het 
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